( (HEADING (NP (NP (NN Loss)) (PP (IN of) (NP (JJ Skeletal) (NN Muscle) (NML (NN HIF) (HYPH -) (NN 1α)) (VBZ Results))) (PP (IN in) (NP (VBN Altered) (NN Exercise) (NN Endurance))))) )
( (HEADING (NP (NN Abstract))) )
( (S (NP-SBJ (NP (DT The) (JJ physiological) (NN flux)) (PP (IN of) (NP (NN oxygen)))) (VP (VBZ is) (ADJP-PRD (JJ extreme) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG exercising) (NP (JJ skeletal) (NN muscle))))))) (. .)) )
( (S (NP-SBJ (NN Hypoxia)) (VP (VBZ is) (ADVP (RB thus)) (NP-PRD (NP (DT a) (JJ critical) (NN parameter)) (PP (IN in) (NP (NN muscle) (NN function)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG influencing) (NP (NP (NP (NN production)) (PP (IN of) (NP (NN ATP)))) (, ,) (NP (NP (NN utilization)) (PP (IN of) (NP (NML (NN energy) (HYPH -) (VBG producing)) (NNS substrates)))) (, ,) (CC and) (NP (NP (NN manufacture)) (PP (IN of) (NP (NML (NN exhaustion) (HYPH -) (VBG inducing)) (NNS metabolites)))))))) (. .)) )
( (S (S (NP-SBJ (NN Glycolysis)) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ central) (NN source)) (PP (IN of) (NP (JJ anaerobic) (NN energy))) (PP-LOC (IN in) (NP (NNS animals)))))) (, ,) (CC and) (S (NP-SBJ-1 (DT this) (JJ metabolic) (NN pathway)) (VP (VBZ is) (VP (VBN regulated) (NP-1 (-NONE- *)) (PP (IN under) (NP (NML (JJ low) (HYPH -) (NN oxygen)) (NNS conditions))) (PP-MNR (IN by) (NP (NP (DT the) (NN transcription) (NN factor) (ADJP (NN hypoxia) (HYPH -) (JJ inducible)) (NN factor) (NN 1α)) (-LRB- -LRB-) (NP (NN HIF) (HYPH -) (NN 1α))))))) (-RRB- -RRB-) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN HIF) (HYPH -) (NN 1α))) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG regulating) (NP (JJ skeletal) (NN muscle) (NN function))))))))) (, ,) (NP-SBJ (PRP we)) (ADVP (NN tissue) (HYPH -) (RB specifically)) (VP (VBD deleted) (NP (NP (DT the) (NN gene)) (VP (VBG encoding) (NP (NP (DT the) (NN factor)) (PP-LOC (IN in) (NP (JJ skeletal) (NN muscle))))))) (. .)) )
( (FRAG (S (NP-SBJ (NP (JJ Significant) (ADJP (NN exercise) (HYPH -) (VBN induced)) (NNS changes)) (PP (IN in) (NP (NP (NN expression)) (PP (IN of) (NP (NNS genes)))))) (VP (VBP are) (ADJP-PRD (JJ decreased) (CC or) (JJ absent) (PP-LOC (IN in) (NP (NP (DT the) (NML (JJ skeletal) (HYPH -) (NN muscle)) (NML (NN HIF) (HYPH -) (NN 1α)) (NN knockout) (NNS mice)) (-LRB- -LRB-) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))))))) (-RRB- -RRB-) (: ;) (S (NP-SBJ-1 (NP (NNS changes)) (PP (IN in) (NP (NP (NNS activities)) (PP (IN of) (NP (JJ glycolytic) (NNS enzymes)))))) (VP (VBP are) (VP (VBN seen) (NP-1 (-NONE- *)) (ADVP (RB as) (RB well))))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBZ is) (NP-PRD (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN activity)) (PP (IN of) (NP (NP (NML (NN rate) (HYPH -) (VBG limiting)) (NNS enzymes)) (PP (IN of) (NP (DT the) (NNS mitochondria))))))) (PP-LOC (IN in) (NP (NP (DT the) (NNS muscles)) (PP (IN of) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NML (JJ citric) (NN acid)) (NN cycle)) (CC and) (NP (VBN increased) (NML (JJ fatty) (NN acid)) (NN oxidation))) (VP (MD may) (VP (VB be) (VP (VBG compensating) (PP (IN for) (NP (VBN decreased) (NN flow))) (PP-MNR (IN through) (NP (DT the) (JJ glycolytic) (NN pathway))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBZ is) (VP (VBN corroborated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT a) (NN finding)) (PP (IN of) (NP (NP (NP (DT no) (JJ significant) (NNS decreases)) (PP (IN in) (NP (NN muscle) (NN ATP)))) (, ,) (CC but) (NP (NP (ADJP (RB significantly) (VBN decreased)) (NNS amounts)) (PP (IN of) (NP (NN lactate))) (PP-LOC (IN in) (NP (NP (DT the) (NN serum)) (PP (IN of) (NP (VBG exercising) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT This) (JJ metabolic) (NN shift)) (PP (PP (IN away) (PP (IN from) (NP (NN glycolysis)))) (CC and) (PP (IN toward) (NP (NN oxidation))))) (VP (VBZ has) (NP (NP (DT the) (NN consequence)) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG increasing) (NP (NN exercise) (NNS times)))))) (PP-LOC (IN in) (NP (DT the) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (VBN repeated) (NN exercise) (NNS trials)) (VP (VBP give) (NP (NN rise)) (PP (IN to) (NP (JJ extensive) (NN muscle) (NN damage))) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADVP (RB ultimately)) (VP (VBG resulting) (PP (IN in) (NP (NP (ADJP (RB greatly) (VBN reduced)) (NN exercise) (NNS times)) (ADJP (JJ relative) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS animals))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN muscle) (NN damage)) (VP (VBN seen) (NP (-NONE- *)))) (VP (VBZ is) (ADJP-PRD (JJ similar) (PP (IN to) (NP (NP (DT that)) (VP (VBN detected) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NNS humans))) (PP (IN in) (NP (NP (NNS diseases)) (VP (VBN caused) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NP (NNS deficiencies)) (PP (IN in) (NP (JJ skeletal) (NN muscle) (NML (NN glycogenolysis) (CC and) (NN glycolysis)))))))))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (DT these) (NNS results)) (VP (VBP demonstrate) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN for) (NP (DT the) (NML (NN HIF) (HYPH -) (CD 1)) (NN pathway))) (PP (IN in) (NP (NP (DT the) (JJ metabolic) (NN control)) (PP (IN of) (NP (NN muscle) (NN function))))))) (. .)) )
( (HEADING (NP (NN Introduction))) )
( (S (PP-TMP (IN During) (NP (NN exercise))) (PP-TMP (IN in) (NP (NN normoxia))) (, ,) (NP-SBJ-1 (NP (DT the) (JJ partial) (NN pressure)) (PP (IN of) (NP (NP (NN oxygen)) (PP-LOC (IN in) (NP (NN muscle) (NN tissue)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB dip) (PP (IN to) (NP (NML (QP (RB as) (JJ low) (IN as) (CD 3.1)) (NNS mm)) (NN Hg))) (, ,) (SBAR-ADV (IN whereas) (S (PP (IN in) (NP (DT the) (NN capillary))) (, ,) (NP-SBJ (PRP it)) (VP (VBZ remains) (PP-PRD (IN at) (NP (NML (CD 38) (NNS mm)) (NN Hg))))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Hoppeler)) (ADVP-ETC (FW et) (FW al.))) (NP-TMP (CD 2003))) (-RRB- -RRB-))))) (. .)) )
( (S (PP-PRP (IN In) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB maintain) (NP (NN effort))))))) (, ,) (NP-SBJ-2 (NML (JJ skeletal) (NN muscle)) (NN exertion)) (VP (MD must) (VP (VB be) (ADJP-PRD (JJ able) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB rely) (PP (IN on) (NP (NP (NNS pathways)) (VP (VBN designed) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB help) (S (NP-SBJ (DT the) (NN tissue)) (VP (VB cope) (PP (IN with) (NP (NN oxygen) (NN stress))) (SBAR-TMP (IN after) (S (NP-SBJ-1 (NML (NN oxygen) (NN delivery)) (NN capacity)) (VP (VBZ is) (VP (VBN exceeded) (NP-1 (-NONE- *)))))))))))))))))))) (. .)) )
( (S (S (NP-SBJ (NP (DT A) (NN switch)) (PP (IN between) (NP (ADJP (JJ aerobic) (CC and) (JJ nonaerobic)) (NN metabolism))) (PP-TMP (IN during) (NP (JJ strenuous) (NN exertion)))) (VP (VBZ requires) (NP-1 (-NONE- *)) (S (NP-SBJ-1 (NNS mechanisms)) (VP (TO to) (VP (VB adjust) (NP (JJ metabolic) (NN function))))))) (, ,) (CC and) (S (NP-SBJ (DT this) (NN need)) (VP (VBZ is) (ADJP-PRD (JJ acute)) (PP (IN in) (NP (NP (VBN extended) (NN exertion)) (PP-LOC (IN in) (NP (JJ skeletal) (NN muscle))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ clear) (SBAR-1 (IN that) (S (NP-SBJ (NP (DT the) (NN transcription) (NN factor)) (NP (NP (NML (NN hypoxia) (HYPH -) (JJ inducible)) (NN factor) (NN 1α)) (-LRB- -LRB-) (NP (NN HIF) (HYPH -) (NN 1α)))) (-RRB- -RRB-) (VP (VBZ is) (NP-PRD (NP (DT an) (JJ essential) (NN factor)) (PP (IN in) (NP (NP (NN maintenance)) (PP (IN of) (NP (NN ATP) (NNS levels))) (PP-LOC (IN in) (NP (NNS cells))))))))) (CIT (-LRB- -LRB-) (NNP Seagroves) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN In) (NP (NN fact))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-1 (NN HIF) (HYPH -) (NN 1α)) (VP (VBZ is) (ADVP (RB typically)) (VP (VBN thought) (PP (IN of) (NP-1 (-NONE- *))) (PP-MNR (IN as) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG acting) (ADVP (RB only)) (PP-TMP (IN during) (NP (NN hypoxia)))))))))) (, ,) (S (S (NP-SBJ (PRP$ its) (NN loss)) (VP (VBZ has) (NP (NP (DT an) (NN effect)) (PP (IN on) (NP (CC both) (ADJP (JJ normoxic) (CC and) (JJ hypoxic)) (NN ATP) (NNS levels))) (PP (IN in) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN tissue) (NNS types)))))) (CIT (-LRB- -LRB-) (NNP Seagroves) (FW et) (FW al.) (CD 2001) (: ;) (NNP Cramer) (FW et) (FW al.) (CD 2003) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP-SBJ (DT this)) (VP (VBZ implicates) (NP (DT the) (NN factor)) (PP (IN in) (NP (NP (NN regulation)) (PP (IN of) (NP (JJ metabolic) (NN function))))) (PP-TMP (ADVP (RB even)) (IN during) (NP (NP (NNS conditions)) (PP (IN of) (NP (JJ normal) (JJ physiologic) (NN oxygenation)))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (JJ skeletal) (NN muscle))) (, ,) (S (S (NP-SBJ-1 (NP (NN signaling)) (PP (IN of) (NP (NN fatigue)))) (VP (VBZ has) (VP (VBN been) (VP (VBN studied) (NP-1 (-NONE- *)) (ADVP (RB extensively)))))) (, ,) (CC and) (S (NP-SBJ (NP (NN signaling)) (PP (IN of) (NP (NN exhaustion)))) (VP (VBZ involves) (, ,) (PP (IN to) (NP (DT some) (NN degree))) (, ,) (NP (NP (VBN elevated) (JJ systemic) (JJ lactic) (NN acid)) (, ,) (NP (NP (DT a) (NN by) (HYPH -) (NN product)) (PP (IN of) (NP (NP (DT the) (JJ glycolytic) (NN pathway)) (PP (IN of) (NP (NN metabolism))))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Myers) (CC and) (NNP Ashley)) (NP-TMP (CD 1997))) (-RRB- -RRB-))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (S (S (NP-SBJ-2 (DT the) (JJ glycolytic) (NN pathway)) (VP (VBZ is) (ADVP (RB intrinsically)) (VP (VBN involved) (NP-2 (-NONE- *)) (PP (IN in) (NP (NN muscle) (NML (NN function) (CC and) (NN fatigue))))))) (, ,) (CC and) (S (NP-SBJ-1 (DT this)) (PP (IN in) (NP (NN turn))) (VP (VBZ is) (VP (VBN linked) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (DT the) (NN response)) (PP (IN to) (NP (NN hypoxia))))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB understand) (SBAR (WHADVP-1 (WRB how)) (S (NP-SBJ (DT the) (JJ primary) (ADJP (NN hypoxia) (HYPH -) (JJ responsive)) (NN transcription) (NN factor)) (VP (VBZ controls) (NP (NML (JJ skeletal) (NN muscle)) (NN function)) (ADVP-1 (-NONE- *T*)))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD targeted) (NP (NN mouse) (JJ skeletal) (NN muscle)) (PP (IN for) (NP (NP (ADJP (NN tissue) (HYPH -) (JJ specific)) (NN deletion)) (PP (IN of) (NP (NN HIF) (HYPH -) (NN 1α))))) (PP-MNR (IN via) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (DT a) (ADJP (RB conditionally) (VBN targeted)) (NN allele)) (PP (IN of) (NP (DT the) (NN gene))))))) (CIT (-LRB- -LRB-) (NNP Ryan) (FW et) (FW al.) (CD 2000) (: ;) (NNP Schipani) (FW et) (FW al.) (CD 2001) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN mouse) (NN strain)) (VP (VBD was) (VP (VBN crossed) (NP-1 (-NONE- *)) (PP (IN into) (NP (NP (DT a) (NN strain)) (ADJP (JJ transgenic) (PP (IN for) (NP (NP (DT the) (ADJP (NP (JJ skeletal) (HYPH -) (NN muscle)) (HYPH -) (JJ specific)) (NML (NML (NN muscle) (NN creatine) (NN kinase)) (-LRB- -LRB-) (NML (NN MCK))) (-RRB- -RRB-) (NN promoter)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ drives) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN cre) (NN recombinase) (NN gene)))))))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Bruning)) (ADVP-ETC (FW et) (FW al.))) (NP-TMP (CD 1998)) (: ;)) (NP (NP (NNP Sauer)) (NP-TMP (CD 1998))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (JJ hypoxic) (NN response))))) (PP-LOC (IN in) (NP (NN muscle)))) (VP (VBZ has) (NP (NP (DT a) (JJ profound) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (DT the) (NN muscle))))) (PP-TMP (IN during) (NP (NN exertion)))) (, ,) (PP (IN with) (NP (NP (NNS effects)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP mimic) (NP (JJ human) (JJ metabolic) (NNS myopathies))))))))))) (. .)) )
( (HEADING (NP (NNS Results) (HYPH /) (NN Discussion))) )
( (S (PP-LOC (IN In) (NP (NP (ADJP (NP (CD 4) (HYPH -) (NN mo)) (HYPH –) (JJ old)) (NNS mice)) (PP (IN with) (NP (NP (DT the) (NML (JJ skeletal) (HYPH -) (NN muscle)) (NML (NN HIF) (HYPH -) (NN 1α)) (NN gene)) (VP (VBN knocked) (NP (-NONE- *)) (PRT (RP out)) (PRN (-LRB- -LRB-) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (-RRB- -RRB-))))))) (, ,) (NP-SBJ-1 (NP (DT the) (NN frequency)) (PP (IN of) (NP (NN excision)))) (VP (VBD was) (VP (VBN evaluated) (NP-1 (-NONE- *)) (PP-MNR (IN through) (NP (NML (JJ real) (HYPH -) (NN time)) (NN PCR) (NNS techniques))))) (. .)) )
( (FRAG (S (NP-SBJ (PRP We)) (VP (VBD saw) (NP (NP (NN deletion) (NNS frequencies)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT those)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB previously)) (PP (IN for) (NP (DT this) (NN cre) (NN recombinase) (NN transgene))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Bruning)) (ADVP-ETC (FW et) (FW al.))) (NP-TMP (CD 1998))) (-RRB- -RRB-)) (PP (IN with) (NP (NP (DT some) (NN variation)) (PP (IN in) (NP (NN penetration)))))))))))) (: ;) (S (NP-SBJ (NP (JJ mean) (NN frequency)) (PP (IN of) (NP (NN deletion)))) (VP (VBD was) (NP-PRD (CD 54.9) (NN %)) (, ,) (PP (IN with) (NP (NP (DT the) (JJS highest) (NN frequency)) (PP (IN of) (NP (NP (NP (ADJP (NN muscle) (HYPH -) (JJ specific)) (NN deletion)) (PP (IN of) (NP (NN HIF) (HYPH -) (NN 1α)))) (VP (VBG being) (NP-PRD (NP (CD 72) (NN %)) (PP-LOC (IN in) (NP (NP (DT the) (NN gastrocnemius)) (PP (IN of) (NP (NP (ADJP (NP (CD 4) (HYPH -) (NN mo)) (HYPH –) (JJ old)) (NNS mice)) (ADJP (JJ homozygous) (PP (IN for) (NP (DT the) (ADJP (NN loxP) (HYPH -) (VBN flanked)) (NN allele)))))))))))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))) (. .)) )
( (FRAG (S (S (NP-SBJ-1 (DT This) (NN transgene)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN at) (NP (DT a) (JJR lower) (NN level))) (PP-LOC (IN in) (NP (JJ cardiac) (NN tissue)))))) (, ,) (CC and) (S (NP-SBJ-2 (JJ cardiac) (NN deletion)) (VP (VBD was) (VP (VBN detected) (NP-2 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))))) (: ;) (S (ADVP (RB however)) (, ,) (NP-SBJ-3 (NP (NN none)) (PP (IN of) (NP (NP (DT the) (NNS phenotypes)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB below)))))) (VP (VBD were) (VP (VBN seen) (NP-3 (-NONE- *)) (PP (IN in) (NP (NP (JJ cardiac) (ADJP (NN myocyte) (HYPH -) (JJ specific)) (NNS deletions)) (PP (IN of) (NP (NN HIF) (HYPH -) (NN 1α))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1A)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ-1 (JJ Gross) (NN muscle) (NNS sections)) (VP (VBD were) (VP (VBN evaluated) (NP-1 (-NONE- *)) (ADVP (ADVP (RB histologically) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VBN evaluate) (NP (CC both) (NP (NN vascularization)) (CC and) (NP (NN fiber) (NN type))) (PRN (-LRB- -LRB-) (NP (NNS Tables) (NML (CD 2) (CC and) (CD 3))) (-RRB- -RRB-)))))) (, ,) (CC and) (ADVP (RB ultrastructurally) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NP (NN number)) (PP (IN of) (NP (NNS mitochondria)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ-1 (DT No) (NNS changes)) (VP (VBD were) (VP (VBN detected) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (DT these) (NNS features))))) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (, ,) (PP (IN except) (PP (IN for) (NP (NP (DT a) (ADJP (ADJP (JJ slight)) (CC but) (ADJP (RB statistically) (JJ significant))) (NN decrease)) (PP (IN in) (NP (NML (NN type) (NN IIA)) (NNS fibers))) (PP-LOC (IN in) (NP (DT the) (NN soleus) (NNS muscles)))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 3)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (JJ Similar) (NML (NN hematocrit) (CC and) (NML (NN blood) (NN hemoglobin))) (NNS levels)) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (CC and) (NML (NML (JJ wild) (HYPH -) (NN type)) (-LRB- -LRB-) (NML (NN WT)))) (-RRB- -RRB-) (NNS mice))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-)))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (MD can) (VP (VB be) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Table) (CD 4)))))))) (, ,) (NP-SBJ (NP (JJ significant) (NNS changes)) (PP (IN in) (NP (ADJP (NP (NN HIF) (HYPH -) (NN 1α)) (HYPH –) (JJ dependent)) (NN gene) (NN expression)))) (VP (VBP occur) (PP-LOC (IN in) (NP (NN muscle))) (PP-TMP (IN during) (NP (NN exercise))) (, ,) (PP (VBG including) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NNS genes)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NN glucose) (NML (NN transport) (CC and) (NN metabolism)))))))))) (. .)) )
( (S (NP-SBJ (NP (NP (NP (JJ Vascular) (JJ endothelial) (NN growth) (NN factor)) (-LRB- -LRB-) (NP (NN VEGF))) (-RRB- -RRB-) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ increases) (NP (JJ vascular) (NN permeability)))))) (, ,) (CC and) (NP (NP (NP (NN glucose) (NN transporter) (CD 4)) (-LRB- -LRB-) (NP (NN GLUT4))) (-RRB- -RRB-) (, ,) (NP (DT the) (ADJP (NN muscle) (HYPH -) (JJ specific)) (NN glucose) (NN transporter)))) (, ,) (VP (VP (VBP show) (NP (NP (VBN increased) (NNS levels)) (PP (IN in) (NP (NN exercise))))) (CC and) (VP (ADVP (RB likely)) (VBP increase) (NP (NP (DT the) (NN availability)) (PP (IN of) (NP (NN glucose))) (PP (IN to) (NP (DT the) (NN muscle)))))) (. .)) )
( (S (S (NP-SBJ-2 (NP (NP (NP (DT The) (ADJP (NN muscle) (HYPH -) (JJ specific)) (NN form)) (PP (IN of) (NP (NN phosphofructokinase)))) (-LRB- -LRB-) (NP (NN PFK) (HYPH -) (NN M))) (-RRB- -RRB-) (, ,) (NP (NP (NN phosphoglycerate) (NN kinase)) (-LRB- -LRB-) (NP (NN PGK))) (-RRB- -RRB-) (, ,) (CC and) (NP (NP (NN lactate) (NN dehydrogenase) (HYPH -) (NN A)) (-LRB- -LRB-) (NP (NN LDH) (HYPH -) (NN A)))) (-RRB- -RRB-) (VP (VBP are) (ADVP (RB also)) (VP (RB up) (HYPH -) (VBN regulated) (NP-2 (-NONE- *)) (PP (IN at) (NP (DT the) (NN mRNA) (NN level))) (PP-MNR (IN by) (NP (NN exercise)))))) (, ,) (CC and) (S (NP-SBJ-1 (DT this) (RB up) (HYPH -) (NN regulation)) (VP (VBZ is) (VP (VBN inhibited) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN HIF) (HYPH -) (NN 1α))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADVP (RB further)) (VP (VBG demonstrating) (SBAR (IN that) (S (NP-SBJ (NN HIF) (HYPH -) (NN 1α)) (VP (VBZ is) (ADJP-PRD (JJ important) (PP (IN for) (NP (JJ transcriptional) (NN response)))) (PP-TMP (IN during) (NP (NML (JJ skeletal) (NN muscle)) (NN activity))))))))))) (. .)) )
( (S (PP (IN In) (NP (NN Table) (CD 5))) (, ,) (NP-SBJ (PRP we)) (VP (VBP show) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (JJ enzymatic) (NN activity))) (PP-LOC (IN in) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (JJ key) (JJ glycolytic) (NNS enzymes)) (VP (VBN affected) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NP (NN deletion)) (PP (IN of) (NP (NN HIF) (HYPH -) (NN 1α)))))))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (MD can) (VP (VB be) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NNS data)))))))) (, ,) (NP-SBJ (NP (JJ several)) (PP (IN of) (NP (NP (DT the) (NNS enzymes)) (VP (VBN assayed) (NP (-NONE- *)))))) (VP (VBD showed) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NN activity)))) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (NN exercise)))))) (. .)) )
( (S (PP (IN In) (ADJP (JJ particular))) (, ,) (NP-SBJ (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ key) (NML (NN rate) (HYPH -) (VBG limiting)) (NNS enzymes)) (, ,) (NP (NN PFK))))))) (, ,) (VP (VBD was) (ADJP-PRD (RB significantly) (JJR lower)) (PP-TMP (VBG following) (NP (NN exercise))) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (PP (VBN compared) (PP (IN to) (NP (NN WT) (NNS mice)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (MD may) (VP (VB have) (NP (NP (NN difficulty)) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG maintaining) (NP (JJ optimal) (NN PFK) (NN activity)))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS responses)) (PP (IN of) (NP (JJ other) (JJ glycolytic) (NNS enzymes))) (PP (IN to) (NP (NN exercise)))) (VP (VBD were) (ADJP-PRD (RB fairly) (JJ similar) (PP (IN between) (NP (NP (NN WT) (NNS mice)) (CC and) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))))) (. .)) )
( (S (NP-SBJ (DT These)) (VP (VBP include) (NP (NP (NP (DT no) (JJ significant) (NNS changes)) (PP (IN in) (NP (NN phosphoglucose) (NN isomerase) (NN activity)))) (CC and) (NP (NP (ADJP (JJ significant) (, ,) (CC yet) (JJ similar)) (, ,) (VBZ decreases)) (PP (IN in) (NP (NML (NML (NN aldolase)) (, ,) (NML (NN glyceraldehyde) (CD 3) (HYPH -) (NN phosphate) (NN dehydrogenase)) (, ,) (CC and) (NML (NN PGK))) (NNS activities)))))) (. .)) )
( (S (NP-SBJ (NP (DT An) (NN exception)) (PP (IN to) (NP (DT this)))) (VP (VBZ is) (SBAR-PRD (IN that) (S (NP-SBJ-1 (NN WT) (NNS muscles)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (ADVP (RB significantly)) (VP (VB increase) (NP (NML (NML (NN pyruvate) (NN kinase)) (-LRB- -LRB-) (NML (NN PK))) (-RRB- -RRB-) (NN activity)))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Table) (CD 4)))) (: ;) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NN LDH) (NN activity)) (VP (VBD was) (ADVP (RB also)) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN WT) (NNS mice))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (DT the) (NN level)) (VP (VBD did) (RB not) (VP (VB reach) (NP (JJ statistical) (NN significance)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Activities)) (PP (IN of) (NP (CC both) (NML (NN PK) (CC and) (NN LDH))))) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN changed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO)) (NNS muscles))) (PP-TMP (VBG following) (NP (NN exercise))))) (. .)) )
( (S (NP-SBJ-1 (NP (VBN Increased) (NNS activities)) (PP (IN of) (NP (NP (NN PK)) (, ,) (CC and) (NP (ADVP (RB subsequently)) (NN LDH))))) (, ,) (VP (MD could) (VP (VB be) (VP (VBN expected) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB lead) (PP (IN to) (NP (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NN lactate))) (PP-LOC (IN in) (NP (DT the) (NN WT) (NNS mice)))) (ADJP (JJ relative) (PP (TO to) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))))))))))) (. .)) )
( (S (PP (IN In) (NP (NN Figure) (NN 3A))) (, ,) (NP-SBJ-1 (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (MD can) (VP (VB be) (VP (VBN seen) (NP-1 (-NONE- *)) (SBAR-2 (IN that) (S (NP-SBJ-3 (NP (DT the) (NN decrease)) (PP (IN in) (NP (NN PFK) (NN activity))) (PP-LOC (IN in) (NP (DT the) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))) (VP (VBZ is) (VP (VBN correlated) (NP-3 (-NONE- *)) (PP (IN with) (NP (NP (DT a) (NN trend)) (VP (VBG approaching) (NP (NN significance) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.10)))) (-RRB- -RRB-))) (PP (IN toward) (NP (NP (DT an) (VBN increased) (NN amount)) (PP (IN of) (NP (NP (NP (NN hexose) (NNS monophosphates)) (-LRB- -LRB-) (NP (NNS HMPs))) (-RRB- -RRB-) (, ,) (SBAR (WHNP-4 (WDT which)) (S (NP-SBJ-4 (-NONE- *T*)) (VP (VBP are) (NP-PRD (JJ pre-PFK) (JJ glycolytic) (NNS metabolites)))))))))))) (, ,) (PP-TMP (VBG following) (NP (NP (NN stimulation)) (PP (IN of) (NP (DT the) (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO)) (NN muscle)))))))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN increase)) (VP (VBD was) (RB not) (PP-PRD (IN due) (IN to) (NP (NP (NNS differences)) (PP (IN in) (NP (NN glucose) (NN uptake))))) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ-1 (NP (NNS animals)) (PP (IN of) (NP (DT both) (NNS genotypes)))) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (ADVP (RB significantly)) (VP (VB increase) (NP (JJ intramuscular) (NN glucose)) (PP (IN to) (NP (DT a) (JJ similar) (NN degree)))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3B)) (-RRB- -RRB-))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ Consistent) (PP (IN with) (NP (NP (VBN decreased) (NN flow)) (PP (IN through) (NP (DT the) (JJ glycolytic) (NN pathway))))))) (, ,) (ADVP (RB however)) (, ,) (NP-SBJ-1 (NP (DT the) (VBN increased) (NN amount)) (PP (IN of) (NP (NNS HMPs)))) (VP (VBD was) (VP (VBN correlated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (VBN increased) (NN muscle) (NN glycogenolysis) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3C)) (-RRB- -RRB-))) (CC and) (NP (NP (VBN increased) (NN depletion)) (PP (IN of) (NP (NP (NN phosphocreatine)) (-LRB- -LRB-) (NP (NN PCr))))))) (-RRB- -RRB-) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3D)) (-RRB- -RRB-)) (, ,) (PP (IN with) (NP (NP (DT a) (JJ resultant) (NN decrease)) (PP (IN in) (NP (DT the) (NML (NN PCr) (HYPH /) (NN ATP)) (NN ratio))) (PP-LOC (IN in) (NP (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO)) (NN muscle))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3E)) (-RRB- -RRB-)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (EX there)) (VP (VBD was) (ADVP (RB only)) (NP-PRD (NP (DT a) (JJ nonsignificant) (NN drop)) (PP (IN in) (NP (JJ overall) (NML (NN muscle) (NN ATP)) (NNS concentrations))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3F)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (JJ Intramuscular) (NNS levels)) (PP (IN of) (NP (NN lactate)))) (VP (VBD did) (VP (VB increase) (PP-LOC (IN in) (NP (CC both) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (CC and) (NP (NN WT) (NNS mice)))) (PP-TMP (IN during) (NP (NN stimulation))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (NN lactate) (NN accumulation)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PP (IN between) (NP (PRP them))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3G)) (-RRB- -RRB-)))) (. .)) )
( (FRAG (S (SBAR-PRP (IN In) (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB evaluate) (SBAR (IN whether) (S (NP-SBJ (DT these) (NNS changes)) (VP (VBD had) (NP (NP (DT any) (NN effect)) (PP (IN on) (NP (JJ overall) (NN muscle) (NN force))))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD measured) (NP (NP (NP (NN force)) (CC and) (NP (NN calcium) (NN release))) (PP-LOC (IN in) (NP (VBN isolated) (JJ single) (NNS fibers)))))) (: ;) (S (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (MD can) (VP (VB be) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NML (NN 4A) (CC and) (NN 4B))))))))) (, ,) (NP-SBJ (EX there)) (VP (VBD were) (NP-PRD (NP (DT no) (JJ significant) (NNS changes)) (PP (IN in) (NP (DT these) (NNS parameters)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (DT the) (NN muscle)) (VP (MD can) (VP (VB compensate) (PP (IN at) (NP (DT this) (NN level))) (PP (IN for) (NP (NP (DT the) (JJ metabolic) (NNS changes)) (VP (VBN induced) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NP (NN loss)) (PP (IN of) (NP (NN HIF) (HYPH -) (NN 1α)))))))))))))))) (. .)) )
( (S (PP (VBN Given) (NP (NP (VBN altered) (NNS levels)) (PP (IN of) (NP (JJ glycolytic) (NN throughput))) (PP (IN without) (NP (NP (JJ significant) (NNS changes)) (PP (IN in) (NP (JJ intramuscular) (NN ATP) (NNS levels))))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ likely)) (SBAR-1 (IN that) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (VBN increased) (NN activity)) (PP (IN of) (NP (JJ oxidative) (NNS pathways))) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO)) (NN muscle)))))))) (. .)) )
( (S (NP-SBJ (VBN Increased) (NN muscle) (JJ oxidative) (NN activity)) (VP (VBZ is) (ADJP-PRD (JJ typical)) (PP-LOC (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (NNS myopathies)) (VP (VBG involving) (NP (NN muscle) (NML (NN glycolysis) (CC or) (NN glycogenolysis))))) (, ,) (PP (VBG including) (NP (NP (NP (NN phosphofructokinase) (NN disease)) (-LRB- -LRB-) (NP (NN PFKD))) (-RRB- -RRB-) (CC and) (NP (NP (NNP McArdle) (POS 's)) (NN disease)))))))) (CIT (-LRB- -LRB-) (NNP Vissing) (FW et) (FW al.) (CD 1996) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBD analyzed) (NP (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NP (NN citrate) (NN synthase)) (-LRB- -LRB-) (NP (NN CS))) (-RRB- -RRB-) (, ,) (NP (NP (DT a) (JJ key) (JJ allosteric) (NN enzyme)) (PP (IN of) (NP (DT the) (NML (JJ citric) (NN acid)) (NN cycle))))))) (, ,) (PP-LOC (IN in) (NP (NML (NML (NN WT)) (CC and) (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO))) (NN muscle))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5A)) (-RRB- -RRB-)) (, ,) (CC and) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ-1 (PRP it)) (VP (VBD was) (VP (RB up) (HYPH -) (VBN regulated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))))))))) (. .)) )
( (S (NP-SBJ (NN CS)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ mitochondrial) (NN enzyme)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ responds) (PP (IN to) (NP (NP (NNS decreases)) (PP (IN in) (NP (NN ATP) (NN concentration))))) (ADVP (RB allosterically)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG allowing) (PP (IN for) (NP (NP (VBN increased) (JJ oxidative) (NN activity)) (PP-LOC (IN in) (NP (DT the) (NNS mitochondria)))))))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-1 (NP (JJ significant) (JJ up) (HYPH -) (NN regulation)) (PP (IN of) (NP (NP (DT the) (JJ mitochondrial) (NN enzyme) (NML (NN beta) (HYPH -) (NN hydroxyacyl)) (NN CoA) (NN dehydrogenase)) (-LRB- -LRB-) (NP (NN B) (HYPH -) (NN HAD))))) (-RRB- -RRB-) (VP (VBD was) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO)) (NN muscle))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5B)) (-RRB- -RRB-)))) (. .)) )
( (S (S (NP-SBJ-1 (NN B) (HYPH -) (NN HAD)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN affected) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NN energy) (NNS levels)) (PP-LOC (IN in) (NP (DT the) (NN cell)))))))) (, ,) (CC and) (S (NP-SBJ (NP (NNS decreases)) (PP (IN in) (NP (NML (NN NADH) (HYPH /) (NN NAD) (SYM +)) (NN concentration) (NNS ratios)))) (VP (VBP cause) (S (NP-SBJ (DT the) (NN enzyme)) (VP (TO to) (VP (VB increase) (NP (NP (JJ mitochondrial) (NN oxidation)) (PP (IN of) (NP (JJ fatty) (NNS acids))))))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Nelson) (CC and) (NNP Cox)) (NP-TMP (CD 2000))) (-RRB- -RRB-)) (. .)) )
( (S (S (NP-SBJ (NP (VBN Increased) (NN activity)) (PP (IN of) (NP (JJ oxidative) (NNS pathways))) (PP-LOC (IN in) (NP (DT the) (NN muscle)))) (VP (MD should) (VP (VB result) (PP (IN in) (NP (ADJP (RBR more) (JJ rapid)) (NN lactate) (NN clearance))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (-NONE- *PRO*)) (PP (IN in) (NP (NN fact))) (VP (VBZ occurs) (PP-LOC (IN in) (NP (NN PFKD) (NNS patients))) (PP-TMP (IN during) (NP (NN exercise))))))))) (: ;) (S (NP-SBJ (DT this) (NN phenomenon)) (VP (VP (VBZ gives) (NP (NN rise)) (PP (IN to) (NP (NP (DT a) (`` “) (JJ second) (NN wind)) ('' ”) (PP-LOC (IN in) (NP (DT these) (NNS patients)))))) (, ,) (CC and) (PP (IN under) (NP (DT some) (NNS circumstances))) (VP (VBZ allows) (PP (IN for) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN exercise) (NN endurance))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Vissing)) (ADVP (FW et) (FW al.)) (NP-TMP (CD 1996))) (: ;) (NP (NP (NNP Haller) (CC and) (NNP Vissing)) (NP-TMP (CD 2002))) (-RRB- -RRB-)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-1 (DT this)) (VP (VBD was) (VP (VBN disputed) (NP-1 (-NONE- *)) (PP (IN in) (NP (CD one) (JJ recent) (NN study))) (PRN (-LRB- -LRB-) (NP (NP (NNP Haller) (CC and) (NNP Vissing)) (NP-TMP (CD 2004))) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ (DT This) (VBN decreased) (NN lactate) (NN accumulation) (RB postexercise)) (ADVP (RB clearly)) (VP (VBZ occurs) (PP-LOC (IN in) (NP (DT the) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (MD can) (VP (VB be) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NN 5C))))))))) (. .)) )
( (S (NP-SBJ (NP (DT This) (ADJP (RB systemically) (JJR lower)) (NN level)) (PP (IN of) (NP (NN lactate) (RB postexercise)))) (VP (VBZ indicates) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (MD may) (VP (VB be) (NP-PRD (NP (DT a) (NN shift)) (PP (IN toward) (NP (DT a) (RBR more) (JJ oxidative) (NN metabolism))) (PP-LOC (IN in) (NP (JJ skeletal) (NN muscle))))))))) (. .)) )
( (FRAG (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN mentioned) (NP-1 (-NONE- *)) (ADVP (RB above))))) (, ,) (NP-SBJ (NP (NNS patients)) (PP (IN with) (NP (NN muscle) (JJ glycolytic) (NNS deficiencies)))) (VP (VBP demonstrate) (NP (CC both) (NP (VBN increased) (ADJP (NN exercise) (HYPH -) (VBN induced)) (NN muscle) (NN damage)) (CC and) (NP (DT a) (`` “) (JJ second) (NN wind))))) ('' ”) (: ;) (S (NP-SBJ (DT the) (JJ latter) (NN phenomenon)) (VP (VBZ allows) (S (NP-SBJ (PRP them)) (VP (TO to) (VP (VB exercise) (PP (IN for) (NP (NP (VBN extended) (NNS periods)) (PP (IN of) (NP (NN time))) (PP (IN at) (NP (JJ submaximal) (NNS levels)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBZ is) (VP (VBN thought) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (PP-PRD (IN due) (IN to) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NNS rates)) (PP (IN of) (NP (JJ oxidative) (NN ATP) (NN production)))))) (, ,) (CC and) (NP (NP (NP (DT a) (VBN decreased) (NN utilization)) (PP (IN of) (NP-2 (-NONE- *RNR*)))) (CC and) (NP (NP (NN need)) (PP (IN for) (NP-2 (-NONE- *RNR*)))) (NP-2 (NN muscle) (NN glycogen)))))))) (CIT (-LRB- -LRB-) (NNP Vissing) (FW et) (FW al.) (CD 1996) (: ;) (NNP Haller) (CC and) (NNP Vissing) (CD 2002) (-RRB- -RRB-)))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB assess) (SBAR (IN whether) (S (NP-SBJ (DT this)) (VP (VBZ is) (ADVP (RB also)) (NP-PRD (NP (DT the) (NN case)) (PP-LOC (IN in) (NP (DT the) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))))))))) (, ,) (NP-SBJ-1 (CC both) (NP (NN WT) (NNS mice)) (CC and) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (VP (VBD were) (VP (VBN subjected) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN endurance) (NNS tests))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB assess) (NP (NN muscle) (NN function))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (ADVP (RB first)) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBD were) (ADJP-PRD (JJ capable) (PP (IN of) (NP (VBN extended) (NN activity)))) (PP-TMP (IN during) (NP (NN exercise))))))))) (, ,) (NP-SBJ-1 (DT the) (NNS animals)) (VP (VBD were) (VP (VBN given) (NP-1 (-NONE- *)) (NP (DT a) (NN swimming) (NN endurance) (NN test)))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (MD can) (VP (VB be) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NN 6A)))))))) (, ,) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBD were) (ADJP-PRD (JJ capable) (PP (IN of) (NP (NML (ADJP (RB significantly) (JJ longer)) (HYPH -) (NN duration)) (NN swimming) (NN activity)))) (SBAR-ADV (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN to) (NP (VBN matched) (NN WT) (NNS controls))) (ADVP-TMP-3 (-NONE- *T*))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (JJ Further) (NN testing)) (VP (VBD was) (VP (VBN done) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NNS parameters)) (PP (IN of) (NP (DT this) (VBN increased) (NN endurance))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBD were) (VP (VBN run) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (DT an) (VBN enclosed) (NN treadmill))) (, ,) (PP (IN with) (NP (NP (DT a) (NML (CD 5) (NN °)) (NN incline)) (CC and) (NP (NP (DT an) (JJ initial) (NN velocity)) (PP (IN of) (NP (NP (CD 10) (NNS m)) (PP (SYM /) (NP (NN min))))) (, ,) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN velocity))) (NP-TMP (QP (DT every) (CD 5)) (NNS min))))))))) (. .)) )
( (S (PP (IN In) (NP (PRP$ their) (JJ first) (NNS runs))) (, ,) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (ADVP (RB again)) (VP (VBD had) (NP (ADJP (RB significantly) (JJR greater)) (NN endurance)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (PRP$ their) (ADJP (RB consistently) (JJR longer)) (NN run) (NNS times)) (PP (VBN compared) (PP (IN to) (NP (NN WT) (NNS controls))))))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.01)))) (, ,) (NP (NN Figure) (NN 6B)) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (NP (PRP it)) (SBAR-3 (-NONE- *EXP*))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (NP-1 (-NONE- *)) (SBAR-3 (IN that) (S (NP-SBJ (NN muscle) (NML (NNS groups) (CC and) (NNS fibers))) (VP (VBP respond) (ADVP (RB differently)) (PP (IN to) (NP (JJ eccentric) (NN exercise) (PRN (-LRB- -LRB-) (ADVP (FW i.e.)) (, ,) (NP (JJ downhill) (NN running)) (-RRB- -RRB-)))) (PP (IN than) (PP (IN to) (NP (JJ concentric) (NN exercise) (PRN (-LRB- -LRB-) (ADVP (FW i.e.)) (, ,) (NP (JJ uphill) (NN running)) (-RRB- -RRB-))))) (CIT (-LRB- -LRB-) (NNP Nardone) (CC and) (NNP Schieppati) (CD 1988) (-RRB- -RRB-)))))))))) (, ,) (NP-SBJ-2 (NP (NNS mice)) (PP (IN from) (NP (DT both) (NNS genotypes)))) (VP (VBD were) (VP (VBN run) (NP-2 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (CD 10) (SYM °)) (NN decline))) (PP (IN with) (NP (NP (DT the) (JJ same) (NML (NN velocity) (CC and) (NML (NN time) (NNS parameters)))) (PP (IN as) (PP (IN in) (NP (DT the) (JJ uphill) (NNS runs)))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Eccentric) (NNS exercises)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB recruit) (ADVP (RB primarily)) (NP (NML (JJ fast) (HYPH -) (NN twitch)) (JJ glycolytic) (NNS fibers)) (PP (IN for) (NP (NN contraction))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBN opposed) (PP (IN to) (NP (NP (NP (DT the) (JJ traditional) (NN recruitment)) (PP (IN of) (NP (JJR slower) (, ,) (JJR smaller) (, ,) (JJ oxidative) (NN motor) (NNS units))) (PP (IN in) (NP (JJ concentric) (NN contraction)))) (, ,) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ (NP (NNS animals)) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN capacity)) (PP (IN for) (NP (NN muscle) (NN oxidation)))))) (VP (MD would) (VP (VB be) (PP-PRD (IN at) (NP (DT an) (NN advantage))) (ADVP-2 (-NONE- *T*)))))))))))))) (CIT (-LRB- -LRB-) (NNP Nardone) (CC and) (NNP Schieppati) (CD 1988) (-RRB- -RRB-))))) (. .)) )
( (S (ADVP (RB Now)) (, ,) (NP-SBJ-1 (NP (DT the) (NN trend)) (PP (IN from) (NP (NML (NML (NN swimming)) (CC and) (NML (RB uphill) (NN running))) (NNS tests)))) (VP (VBD was) (VP (VBN reversed) (NP-1 (-NONE- *)) (, ,) (SBAR-ADV (IN with) (S (NP-SBJ-2 (NN WT) (NNS mice)) (ADJP-PRD (JJ able) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB run) (PP (IN for) (NP (NP (DT a) (ADJP (RB significantly) (JJR longer)) (NN time)) (PP (IN than) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))))))))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.05)))) (, ,) (NP (NN Figure) (NN 6C)) (-RRB- -RRB-)))) (. .)) )
( (S (S (PP-LOC (IN Within) (NP (NNS genotypes))) (, ,) (NP-SBJ (NN WT) (NNS mice)) (VP (VBD ran) (PP (IN for) (NP (NP (ADJP (RB significantly) (JJR longer)) (NNS times)) (PP-1 (-NONE- *ICH*)))) (ADVP (RB downhill)) (PP-1 (IN than) (ADVP (RB uphill))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.01)))) (-RRB- -RRB-)))) (: ;) (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VP (VBD did) (NP (DT the) (NN reverse))) (, ,) (CC and) (VP (VBD ran) (PP (IN for) (NP (NP (ADJP (RB significantly) (JJR shorter)) (NNS times)) (ADVP (RB downhill) (PP (IN than) (ADVP (RB uphill)))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))))) (. .)) )
( (S (S (NP-SBJ (NN Substrate) (NN utilization)) (VP (VBZ confirms) (NP (NP (DT the) (NN shift)) (PP (IN toward) (NP (JJ glycolytic) (NNS fibers))) (PP (IN in) (NP (JJ downhill) (NN running)))))) (: ;) (S (NP-SBJ (DT both) (NNS genotypes)) (VP (VBD had) (NP (RBR higher) (JJ average) (NML (NML (JJ respiratory) (NN exchange) (NN ratio)) (-LRB- -LRB-) (NML (NN RER))) (-RRB- -RRB-) (NNS values)) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG running) (ADVP (RB downhill)) (ADVP-TMP-2 (-NONE- *T*)) (PP (VBN compared) (PP (IN with) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG running) (ADVP (RB uphill))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 6D) (CC and) (NN 6E))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (NN PFKD)) (CC and) (NP (NP (NNP McArdle) (POS 's)) (NN disease))) (VP (VBP demonstrate) (NP (NP (JJ significant) (JJ myopathic) (NNS effects)) (PP-LOC (IN in) (NP (NN muscle))) (, ,) (PP (VBG including) (NP (NP (NN soreness) (CC and) (NN cramping)) (VP (VBN induced) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NP (NNS bouts)) (PP (IN of) (NP (NN exercise)))))))))) (. .)) )
( (S (PP-TMP (IN After) (NP (NP (CD 1) (NN d)) (PP (IN of) (NP (NP (NN recovery)) (PP (IN from) (NP (NN endurance) (NN testing))))))) (, ,) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBD had) (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NP (DT the) (NN MM) (NN isoform)) (PP (IN of) (NP (NN creatine) (NN kinase)))))) (PP-LOC (IN in) (NP (PRP$ their) (NN serum))) (PRN (-LRB- -LRB-) (NP (JJ unpublished) (NNS data)) (-RRB- -RRB-)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ indicative) (PP (IN of) (NP (JJ skeletal) (NN muscle) (NN damage)))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (ADVP (RB further)) (VP (VB investigate) (NP (DT this) (NN finding))))) (, ,) (NP-SBJ-1 (NNS mice)) (VP (VBD were) (VP (VBN run) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NN treadmill))) (ADVP-TMP (RB daily)) (PP-TMP (IN for) (NP (CD 4) (NNS d))))) (. .)) )
( (S (S (PP-TMP (IN By) (NP (DT the) (JJ second) (NN day))) (, ,) (NP-SBJ (NP (DT the) (NN trend)) (PP (IN for) (NP (VBN increased) (NN endurance))) (PP-LOC (IN in) (NP (DT the) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))) (VP (VBD was) (ADJP-PRD (JJ absent)))) (, ,) (CC and) (S (PP-TMP (IN by) (NP (DT the) (JJ final) (NN day))) (, ,) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBD were) (VP (VBG running) (PP (IN for) (NP (NP (ADJP (RB significantly) (JJR shorter)) (NNS times)) (SBAR (IN than) (S (NP-SBJ (PRP they)) (VP (VBD had) (VP (-NONE- *?*) (PP-TMP (IN on) (NP (DT the) (JJ first) (NN day)))))))))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.01)))) (, ,) (NP (NN Figure) (NN 7A)) (-RRB- -RRB-)) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (DT a) (NML (VBN repeated) (NNS measures)) (NN ANOVA)) (VP (VBN performed) (NP (-NONE- *)) (PP (IN on) (NP (NN run) (NNS times))))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN response)) (PP (IN of) (NP (DT the) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (PP (IN to) (NP (DT the) (NN protocol)))) (VP (VBD was) (ADJP-PRD (ADJP (RB significantly) (JJ different)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (NN WT) (NNS mice))))))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (JJ Histological) (NN examination)) (PP (IN of) (NP (NN gastrocnemius) (NN tissue))) (PP-TMP (VBG following) (NP (NP (CD 1) (NN d)) (PP (IN of) (NP (NN recovery)))))) (VP (VBD revealed) (NP (NP (ADJP (RB significantly) (JJR greater)) (NNS amounts)) (PP (IN of) (NP (NN muscle) (NN damage))) (PP-LOC (IN in) (NP (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO)) (NN tissue))) (PP (IN than) (NP (NN WT) (NN tissue)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 7B)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (NP (NN Staining)) (PP (IN of) (NP (NP (DT the) (NN tissue)) (PP (IN for) (NP (NP (VBG proliferating) (JJ cellular) (JJ nuclear) (NN antigen)) (-LRB- -LRB-) (NP (NN PCNA))))))) (-RRB- -RRB-) (CC and) (NP (NP (NNS counts)) (PP (IN of) (NP (JJ positive) (NNS nuclei)))) (CIT (-LRB- -LRB-) (NNP Olive) (FW et) (FW al.) (CD 1995) (-RRB- -RRB-))) (ADVP (RB also)) (VP (VBD revealed) (NP (NP (NP (JJR more) (NN cell) (NN division)) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (PP (IN than) (PP (IN in) (NP (NNS WTs))))) (, ,) (NP (DT another) (NN indication) (SBAR (IN that) (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBD had) (VP (VBN been) (ADJP-PRD (NN subject) (PP (IN to) (NP (JJR greater) (NN tissue) (NN damage)))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 7C) (CC and) (NN 7D))) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN noted) (NP-1 (-NONE- *)) (ADVP (RB above))))) (, ,) (NP-SBJ-2 (CC both) (NP (NN PFKD)) (CC and) (NP (NP (NNP McArdle) (POS 's)) (NN disease))) (VP (VBP are) (VP (VBN marked) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NP (VBN increased) (JJ resting) (JJ intramuscular) (NNS levels)) (PP (IN of) (NP (NN glycogen)))) (, ,) (NP (NP (DT a) (NN failure) (S-3 (-NONE- *ICH*))) (PP (IN of) (NP (NN serum) (NN lactate))) (S-3 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB rise) (PP (IN during) (NP (NN exertion))))))) (, ,) (NP (DT an) (ADJP (NN exercise) (HYPH -) (VBN induced)) (`` “) (JJ second) (NN wind)) (, ,) ('' ”) (CC and) (NP (NP (NNS signs)) (PP (IN of) (NP (NN muscle) (NN damage))) (PP-TMP (VBG following) (NP (NN exertion))) (, ,) (PP (VBG including) (NP (NP (VBN elevated) (NNS levels)) (PP (IN of) (NP (NN creatine) (NN kinase))) (PP-LOC (IN in) (NP (DT the) (NN serum)))))))) (CIT (-LRB- -LRB-) (NNP Tarui) (FW et) (FW al.) (CD 1965) (: ;) (NNP Layzer) (FW et) (FW al.) (CD 1967) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-1 (NN PFKD)) (VP (VBZ is) (VP (VBN characterized) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NP (VBN elevated) (NNS levels)) (PP (IN of) (NP (NNS HMPs)))) (CIT (-LRB- -LRB-) (NNP Tarui) (FW et) (FW al.) (CD 1965) (: ;) (NNP Layzer) (FW et) (FW al.) (CD 1967) (: ;) (NNP Argov) (FW et) (FW al.) (CD 1987) (: ;) (NNP Grehl) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-)) (CC and) (NP (NP (JJR greater) (NN PCr) (NN utilization)) (PP-TMP (IN during) (NP (NN contraction)))))) (CIT (-LRB- -LRB-) (NNP Argov) (FW et) (FW al.) (CD 1987) (: ;) (NNP Grehl) (FW et) (FW al.) (CD 1998) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP see) (NP (NP (JJ many)) (PP (IN of) (NP (NP (DT these) (NNS hallmarks)) (PP (IN of) (NP (NN muscle) (NNS deficiencies))) (PP (IN in) (NP (JJ glycolytic) (NN processing)))))) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))) (. .)) )
( (S (NP-SBJ (DT The) (NNS effects)) (VP (VBP are) (RB not) (ADJP-PRD (JJ likely)) (PP-PRP (IN due) (IN to) (NP (NN glucose) (NN uptake))) (, ,) (SBAR-ADV (IN as) (S (S (NP-SBJ (NML (NML (NN WT)) (CC and) (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO))) (JJ intramuscular) (NN glucose) (NNS levels)) (VP (VBD were) (RB not) (ADJP-PRD (JJ different) (UCP (PP (IN at) (NP (NN rest))) (CC or) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG following) (NP (NN stimulation)))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (NN 3B)))) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP-SBJ (NP (DT both) (NNS types)) (PP (IN of) (NP (NNS mice)))) (VP (VBD responded) (ADVP (RB similarly)) (PP (IN to) (NP (DT a) (NML (NN glucose) (NN tolerance)) (NN test))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8A)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (NML (NML (JJ Periodic) (NN acid) (HYPH –) (NN Schiff)) (-LRB- -LRB-) (NML (NN PAS))) (-RRB- -RRB-) (NN staining)) (PP (IN of) (NP (NP (NN tissue)) (PP (IN from) (NP (NP (NNS mice)) (PP (IN of) (NP (DT both) (NNS genotypes)))))))) (VP (VBD gave) (NP (NP (JJ further) (NN demonstration)) (PP (IN of) (NP (VBN increased) (NN glycogen) (NNS levels)))) (PP-LOC (IN in) (NP (NP (VBG resting) (NNS muscles)) (PP (IN from) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8B)) (-RRB- -RRB-))) (. .)) )
( (S (PP (VBN Given) (NP (NP (NP (DT the) (NNS differences)) (PP (IN in) (NP (NN performance)))) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (PP (IN in) (NP (ADJP (JJ eccentric) (CC and) (JJ concentric)) (NN exercise)))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ clear)) (SBAR-1 (IN that) (S (NP-SBJ (NP (DT the) (NML (NN HIF) (HYPH -) (CD 1)) (NN pathway)) (CC and) (NP (JJ hypoxic) (NN response))) (VP (VBP have) (NP (NP (DT a) (JJ central) (NN role)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG determining) (NP (NP (DT the) (NN capacity)) (PP (IN for) (NP (NN work) (CC and) (NN endurance)))) (PP-MNR (IN through) (NP (NP (NN regulation)) (PP (IN of) (NP (NN glycolysis))))))))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADVP (RB also)) (ADJP-PRD (JJ clear)) (SBAR-1 (IN that) (S (NP-SBJ (DT these) (NNS mice)) (VP (VP (MD will) (VP (VB provide) (NP (DT an) (JJ important) (JJ model) (NN system)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN physiology)) (PP (IN of) (NP (NN muscle) (NN response)))) (PP-TMP (IN during) (NP (NP (NN work)) (CC and) (NP (NN oxygen) (NN depletion))))))))) (, ,) (CC and) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ useful) (PP (IN as) (NP (NP (DT a) (NN model)) (PP (IN for) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (ADJP (RB very) (VBG debilitating)) (JJ myopathic) (NNS syndromes))) (PP-LOC (IN in) (NP (NNS humans)))))))))))))) (. .)) )
( (HEADING (NP (NNS Materials) (CC and) (NNS Methods))) )
( (HEADING (NP (NN Mouse) (NML (NNS strains) (CC and) (NNS crosses)) (. .))) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NML (NN HIF) (HYPH -) (NN 1α)) (ADJP (NN loxP) (HYPH -) (VBN flanked)) (NN allele) (NN mouse) (NNS stocks)) (VP (VBN backcrossed) (NP (-NONE- *)) (PP (IN into) (NP (DT a) (NML (NN C57Bl6) (HYPH /) (NN J)) (NN background)))))))) (. .)) )
( (S (NP-SBJ-1 (DT These)) (VP (VBD were) (VP (VBN crossed) (NP-1 (-NONE- *)) (PP (IN into) (NP (NP (DT a) (NML (NN C57Bl6) (HYPH /) (NN J)) (NN strain)) (VP (VBG containing) (NP (DT the) (NML (NN MCK) (HYPH /) (NN cre)) (NN transgene))))))) (. .)) )
( (S (NP-SBJ (NNS Controls)) (VP (VBD were) (PP (IN in) (NP (DT all) (NNS cases))) (NP-PRD (NP (NNS littermates)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (VP (VBN genotyped) (NP-1 (-NONE- *)) (PP (IN as) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG containing) (NP (NP (RB only) (DT the) (NML (NN loxP) (HYPH -) (VBN flanked)) (NML (NN HIF) (HYPH -) (NN 1α)) (NN allele)) (CC or) (NP (RB only) (DT the) (NML (NN MCK) (HYPH /) (NN cre)) (NN transgene)))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT No) (JJ phenotypic) (NNS differences)) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (CD two) (NNS controls))) (, ,) (SBAR-PRP (IN so) (S (NP-SBJ-2 (PRP they)) (VP (VBD were) (VP (VBN considered) (NP-2 (-NONE- *)) (ADVP (RB interchangeably)) (PP (IN as) (NP (NN WT) (NN control) (NNS animals))))))))) (. .)) )
( (HEADING (NP (NP (NP (NN Genotyping)) (CC and) (NP (NML (JJ real) (HYPH -) (NN time)) (NN PCR))) (PP (IN for) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NN deletion))))) )
( (S (NP-SBJ-1 (NP (NNS Mice)) (PP (IN from) (NP (DT the) (JJ above) (NNS crosses)))) (VP (VBD were) (VP (VBN genotyped) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NN DNA)) (VP (VBN extracted) (NP (-NONE- *)) (PP (IN from) (NP (NN tail) (NNS sections))))))))) (. .)) )
( (S (NP-SBJ-1 (NN DNA)) (VP (VBD was) (ADVP (RB then)) (VP (VBN extracted) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NML (NN gastrocnemius) (, ,) (NN heart) (, ,) (NN liver) (, ,) (CC and) (NN uterus))) (PP (IN of) (NP (CD eight) (ADJP (NP (CD 4) (HYPH -) (NN mo)) (HYPH –) (JJ old)) (, ,) (NML (NN loxP) (HYPH -) (VBN flanked)) (ADJP (ADJP (NP (NN HIF) (HYPH -) (NN 1α)) (HYPH –) (JJ positive)) (CC and) (ADJP (NP (NN MCK) (HYPH /) (NN cre)) (HYPH –) (JJ positive))) (NNS mice))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN HIF) (HYPH -) (NN 1α)) (NNS levels)) (VP (VBD were) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NML (JJ real) (HYPH -) (NN time)) (NN PCR) (NN analysis))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (NNP Universal) (NNP PCR) (NNP Master) (NNP Mix) (NNP Kit) (PRN (-LRB- -LRB-) (NP (NP (NNP Applied) (NNP Biosystems)) (, ,) (NP-LOC (NNP Foster) (NNP City)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (CC and) (NP (DT the) (NNP ABI) (NNP Prism) (CD 7700) (NNP Sequence) (NNP Detector) (PRN (-LRB- -LRB-) (NP (NNP Applied) (NNP Biosystems)) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ (NP (NNS Conditions)) (PP (IN for) (NP (DT the) (NN PCR)))) (VP (VBD were) (NP-PRD (NP (NP (CD one) (NML (CD 10) (HYPH -) (NN min)) (NN incubation)) (PP (IN at) (NP (CD 95) (SYM °) (NNP C) (PRN (-LRB- -LRB-) (NP (NN polymerase) (NN activation)) (-RRB- -RRB-))))) (, ,) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP (NP (NP (CD 40) (NNS cycles)) (PP (IN of) (NP (CD 15) (NNS s))) (PP (IN at) (NP (CD 95) (NN °C))) (PRN (-LRB- -LRB-) (NP (NN denaturation)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 1) (NN min)) (PP (IN at) (NP (CD 60) (NN °C)))))) (PRN (-LRB- -LRB-) (VP (VB anneal) (SYM /) (VB extend)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN degree)) (PP (IN of) (NP (NN excision)))) (VP (VBD was) (VP (VBN calculated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG comparing) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NN DNA) (NNS levels)) (PP (IN to) (NP (NML (NN c) (HYPH -) (NN Jun)) (NN DNA) (NNS levels)))))))) (. .)) )
( (FRAG (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NML (JJ real) (HYPH -) (NN time)) (NN PCR) (NML (NNS primers) (CC and) (NN probe))) (VP (VBD were) (SBAR-PRD (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBZ follows)))))) (: :) (NP-PRD (NP (NP (JJ forward) (NN primer)) (, ,) (NP (NML (NN HIFLOX501) (HYPH /) (NN F)) (NML (CD 5) (SYM ′)) (HYPH -) (NN CTATGGAGGCCAGAAGAGGGTAT) (HYPH -) (CD 3) (SYM ′))) (: ;) (NP (NP (JJ reverse) (NN primer)) (, ,) (NP (NML (NN HIFLOX574) (HYPH /) (NN R)) (NML (CD 5) (SYM ′)) (HYPH -) (NN CCCACATCAGGTGGCTCATAA) (HYPH -) (CD 3) (SYM ′))) (: ;) (NP (NP (NN probe)) (, ,) (NP (NML (NN HIFLOX) (HYPH /) (NN P)) (NML (CD 5) (SYM ′)) (HYPH -) (-LRB- -LRB-) (NN 6FAM) (-RRB- -RRB-) (NN AGATCCCTTGAAGCTAG) (-LRB- -LRB-) (NN MGBNFQ) (-RRB- -RRB-) (HYPH -) (CD 3) (SYM ′)))) (. .)) )
( (HEADING (NP (NP (NN Muscle) (NN histology)) (CC and) (NP (NN electron) (NN microscopy)) (. .))) )
( (S (NP-SBJ-1 (VBN Paraffined) (NN gastrocnemius) (NNS sections)) (VP (VBD were) (VP (VP (VBN deparaffinized) (NP-1 (-NONE- *))) (CC and) (VP (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN Gill) (CD II) (NN hematoxylin)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Sections)) (VP (VBD were) (ADVP (RB then)) (VP (VP (VBN washed) (NP-1 (-NONE- *)) (ADVP (RB successively)) (PP-LOC (IN in) (NP (NP (NN water)) (, ,) (NP (DT a) (VBG bluing) (NN agent)) (, ,) (NP (NP (NN water)) (ADVP-TMP (RB again))) (, ,) (CC and) (NP (NML (CD 95) (NN %)) (NN ethanol))))) (, ,) (CC and) (VP (VBD restained) (NP-1 (-NONE- *)) (PP (IN with) (NP (NN eosin)))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Hematoxylin) (CC and) (NN eosin)) (NN staining)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NML (NML (NML (DT the) (NNP University)) (PP (IN of) (NP (NNP California))) (PP-LOC (IN at) (NP (NNP San) (NNP Diego)))) (-LRB- -LRB-) (NML (NNP UCSD))) (-RRB- -RRB-) (NNP Cancer) (NNP Center) (NNP Histology) (NNP Resource) (PRN (-LRB- -LRB-) (NP (NP (NNP La) (NNP Jolla)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NN Imaging)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (NP (NNS sections)) (VP (VBN mounted) (NP (-NONE- *)) (PP (IN on) (NP (NNS slides)))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NNP Cytoseal) (CD 60)))) (PRN (-LRB- -LRB-) (NP (NP (NNP VWR)) (, ,) (NP-LOC (NNP West) (NNP Chester)) (, ,) (NP-LOC (NNP Pennsylvania)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NN Electron) (NN microscopy)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ standard) (NNS methods))) (PP-LOC (IN on) (NP (NN gastrocnemius) (NN muscle))))) (. .)) )
( (S (ADVP (RB Briefly)) (, ,) (NP-SBJ (NN fixation)) (VP (VBD was) (PP-PRD (IN by) (NP (NML (CD 25.5) (NN %)) (NN glutaraldehyde))) (PP-LOC (IN in) (NP (NML (NML (CD 0.1) (NN M)) (NN sodium) (NN cacodylate)) (NN buffer) (PRN (-LRB- -LRB-) (NP (NN pH) (CD 7.4)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (NN Postfix)) (VP (VBD was) (PP-PRD (IN in) (NP (NML (CD 1) (NN %)) (NN osmium) (NN tetroxide)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN section)) (VP (VBD was) (VP (VP (VBN stained) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NML (CD 2) (NN %)) (NN uranyl) (NN acetate)) (PP-LOC (IN in) (NP (NN sodium) (NN maleate) (NN buffer) (PRN (-LRB- -LRB-) (NP (NN pH) (CD 5.2)) (-RRB- -RRB-))))))) (, ,) (VP (ADVP (RB then)) (VBN placed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Epon) (NN resin)))) (PRN (-LRB- -LRB-) (NP (NP (NN VWR)) (, ,) (NP-LOC (NNP West) (NNP Chester)) (, ,) (NP-LOC (NNP Pennsylvania)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)) (, ,) (CC and) (VP (VBN cured) (NP-1 (-NONE- *)) (ADVP-TMP (RB overnight)) (PP (IN at) (NP (CD 60) (SYM °) (NNP C)))))) (. .)) )
( (S (NP-SBJ-1 (NN Fiber) (NN typing)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NML (JJ metachromatic) (NN dye) (NN ATPase)) (NN method)))) (CIT (-LRB- -LRB-) (NNP Ogilvie) (CC and) (NNP Feeback) (CD 1990) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NN PAS) (NN staining)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-2 (-NONE- *))))))) (CIT (-LRB- -LRB-) (NNP Bancroft) (CC and) (NNP Stevens) (CD 1996) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NP (NN Assessment)) (PP (IN of) (NP (NN exhaustion))) (. .))) )
( (S (NP-SBJ-1 (NP (JJ Untrained) (, ,) (ADJP (NN age) (HYPH -) (VBN matched)) (NN WT) (NNS mice)) (CC and) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 10))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 14))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN run) (NP-1 (-NONE- *)) (PP (CC either) (PP (IN on) (NP (DT an) (NN Omnipacer) (NN treadmill)) (PRN (-LRB- -LRB-) (NP (NP (NNP Columbus) (NNP Instruments)) (, ,) (NP-LOC (NNP Columbus)) (, ,) (NP-LOC (NNP Ohio)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (CC or) (PP (IN on) (NP (DT an) (NML (VBN enclosed) (HYPH -) (NN chamber)) (JJ modular) (NN treadmill) (PRN (-LRB- -LRB-) (NP (NNP Columbus) (NNP Instruments)) (-RRB- -RRB-))))) (PP (IN with) (NP (DT a) (NML (CD 5) (SYM °)) (NN incline))) (PP (IN at) (NP (NP (DT an) (JJ initial) (NN velocity)) (PP (IN of) (NP (NP (CD 10) (NNS m)) (PP (SYM /) (NP (NN min))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Velocity)) (VP (VBD was) (VP (VBN increased) (NP-1 (-NONE- *)) (PP (IN by) (NP (NP (CD 2) (NNS m)) (PP (SYM /) (NP (NN min))))) (NP-TMP (QP (DT every) (CD 5)) (NNS min)) (PP-TMP (IN during) (NP (DT the) (NN assessment))))) (. .)) )
( (S (NP-SBJ-1 (NN Exhaustion)) (VP (VBD was) (VP (VBN determined) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT the) (NN point)) (SBAR (WHPP-2 (IN at) (WHNP (WDT which))) (S (NP-SBJ (DT the) (NN animal)) (VP (MD would) (RB not) (VP (VB resume) (VP (VBG running) (PP-2 (-NONE- *T*)) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBN provoked) (NP (-NONE- *)) (PP-MNR (IN through) (NP (DT a) (NML (JJ low) (HYPH -) (NN voltage)) (NN power) (NN grid))) (ADVP-TMP-3 (-NONE- *T*)))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Gas) (NN flow) (PRN (-LRB- -LRB-) (NP (NN O2) (CC and) (NN CO2)) (-RRB- -RRB-))) (PP (PP (IN into) (NP-2 (-NONE- *RNR*))) (CC and) (PP (IN out) (PP (IN of) (NP-2 (-NONE- *RNR*)))) (NP-2 (DT the) (VBN enclosed) (NN chamber) (NN treadmill)))) (VP (VP (VBD was) (VP (VBN monitored) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (NNP Paramax) (NN O2) (NN sensor)) (CC and) (NP (DT a) (NN CO2) (NN sensor)) (PRN (-LRB- -LRB-) (NP (NNP Columbus) (NNP Instruments)) (-RRB- -RRB-))))))) (CC and) (VP (VBN analyzed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NNP Oxymax) (NN software) (PRN (-LRB- -LRB-) (NP (NNP Columbus) (NNP Instruments)) (-RRB- -RRB-))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (JJ metabolic) (NNS parameters))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (JJ downhill) (NN running)) (NN assessment) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 8))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 6))))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP (IN in) (NP (DT the) (NML (VBN enclosed) (HYPH -) (NN chamber)) (JJ modular) (NN treadmill))) (PP (IN at) (NP (DT a) (NML (CD 10) (SYM °)) (NN decline))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (JJ same) (NN protocol)) (PP (IN as) (NP (RB above)))))))) (. .)) )
( (S (PP (IN In) (NP (DT the) (NML (NN swimming) (NN exhaustion)) (NN assessment))) (, ,) (NP-SBJ-1 (NP (DT a) (JJ second) (NN group)) (PP (IN of) (NP (NML (NN WT) (CC and) (NML (NN HIF) (HYPH -) (NN 1α))) (NNS KOs))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 8)) (PP (IN for) (NP (DT each) (NN class))))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN placed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT a) (NML (CD 30) (SYM °) (NNP C)) (NN water) (NN bath)) (PP (IN with) (NP (JJ mild) (NN turbulence))))))) (. .)) )
( (S (NP-SBJ-1 (NN Exhaustion)) (VP (VBD was) (VP (VBN determined) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT the) (NN point)) (SBAR (WHPP-2 (IN at) (WHNP (WDT which))) (S (NP-SBJ (DT the) (NN animal)) (VP (VBD experienced) (NP (NP (CD three) (JJ successive) (NNS periods)) (PP (IN below) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (QP (JJR more) (IN than) (CD 3)) (NNS s)))))) (PP-2 (-NONE- *T*))))))))))) (. .)) )
( (HEADING (NP (NP (VBN Isolated) (NN stimulation)) (CC and) (NP (JJ metabolic) (NN analysis)) (. .))) )
( (S (NP-SBJ-1 (DT The) (NN Achilles) (NN tendon)) (VP (VBD was) (VP (VP (ADVP (RB surgically)) (VBN freed) (NP-1 (-NONE- *)) (PP (IN from) (NP (JJ live) (, ,) (VBN anesthetized) (NNS mice))) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 8))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 6))))) (-RRB- -RRB-))) (CC and) (VP (VBN attached) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT a) (NN force) (NN transducer))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB record) (NP (JJ contractile) (NN force)))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Muscles)) (VP (VBD were) (ADVP (RB electrically)) (VP (VBN stimulated) (NP-1 (-NONE- *)) (PP-MNR (IN through) (NP (NP (NN excitation)) (PP (IN of) (NP (DT the) (JJ sciatic) (NN nerve))))))) (. .)) )
( (S (NP-SBJ (NN Stimulation)) (VP (VBD was) (PP-PRD (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NML (QP (CD 8) (HYPH –) (CD 10)) (HYPH -) (NN V)) (JJ direct) (JJ titanic) (NNS contractions))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (CD 200) (HYPH -) (NN ms)) (NNS trains)) (PP (IN at) (NP (CD 70) (NN Hz))) (PP (IN with) (NP (NML (CD 0.2) (NN ms)) (NN duration)))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Initial) (NN frequency)) (PP (IN of) (NP (JJ tetanic) (NN contraction)))) (VP (VP (VBD was) (NP-PRD (NP (CD one)) (NP-ADV (QP (DT every) (CD 8)) (NNS s)))) (CC and) (VP (VBD was) (VP (VBN increased) (NP-1 (-NONE- *)) (NP-TMP (QP (DT every) (CD 2)) (NNS minutes)) (PP (IN to) (NP (NP (NP (CD one)) (NP-TMP (QP (DT every) (CD 4)) (NNS s))) (CC and) (NP (NP (CD one)) (NP-TMP (QP (DT every) (CD 3)) (NNS s))))) (, ,) (PP (IN up) (PP (IN to) (NP (NP (DT the) (NN end) (NN point)) (PP (IN of) (NP (CD 6) (NNS min))))))))) (. .)) )
( (S (NP-SBJ-1 (VBN Isolated) (NNS muscles)) (VP (VBD were) (ADVP (RB then)) (VP (VP (ADVP (RB immediately)) (VBN harvested) (NP-1 (-NONE- *))) (CC and) (VP (VBN snap) (HYPH -) (VBN frozen) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NML (NN ATP) (, ,) (NN lactate) (, ,) (NN phosphocreatine) (, ,) (CC and) (NN glycogen)) (NNS analyses)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Samples)) (VP (VBD were) (VP (VP (VBN freeze) (HYPH -) (VBN dried) (NP-1 (-NONE- *))) (CC and) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ enzymatic) (NN assay))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBZ has) (VP (VBN been) (ADVP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *))))))) (CIT (-LRB- -LRB-) (NNP Bergmeyer) (CD 1974) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ unstimulated) (NN gastrocnemius) (NN muscle)) (PP (IN from) (NP (DT each) (NN mouse)))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN as) (NP (DT a) (JJ resting) (NN control))))) (. .)) )
( (HEADING (NP (NP (NML (JJ Real) (HYPH -) (NN time)) (NN PCR) (NN measurement)) (PP (IN of) (NP (NN gene) (NN expression))) (. .))) )
( (S (PP-PRP (IN For) (NP (JJ basal) (NN gene) (NN expression) (NNS levels))) (, ,) (NP-SBJ-1 (JJ total) (NN RNA)) (VP (VBD was) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NN gastrocnemius) (NN tissue)) (PP (IN from) (NP (NP (CD seven) (NN WT) (NML-2 (-NONE- *RNR*))) (CC and) (NP (CD five) (NN HIF) (HYPH -) (NN 1α) (NML-2 (-NONE- *RNR*))) (NML-2 (NNS KOs)))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN RNA) (HYPH -) (NN Bee) (PRN (-LRB- -LRB-) (NP (NP (NNP Tel) (HYPH -) (NNP Test)) (, ,) (NP-LOC (NNP Friendswood)) (, ,) (NP-LOC (NNP Texas)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Reverse) (NN transcription)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (NNP Superscript) (NNP First) (NNP Stand) (NNP Synthesis) (NNP System)) (PP (IN for) (NP (NN RT) (HYPH -) (NN PCR))) (PRN (-LRB- -LRB-) (NP (NP (NNP Invitrogen)) (, ,) (NP-LOC (NNP Carlsbad)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NN Amplification)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NNP ABIPrism) (CD 7700)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP (RB above))))))))) (. .)) )
( (S (NP-SBJ (JJ Reverse) (NN transcription) (NML (JJ real) (HYPH -) (NN time)) (NN PCR) (NML (NNS primers) (CC and) (NNS probes))) (VP (VBD were) (SBAR-PRD (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBZ follows))))) (. .)) )
( (FRAG (FRAG (PP (IN For) (NP (NN PGK) (HYPH -) (CD 1))) (: :) (NP (NP (JJ reverse) (NN primer)) (, ,) (NP (NML (NN PGK) (HYPH /) (NN R)) (NML (CD 5) (SYM ′)) (HYPH -) (NN CAGGACCATTCCAAACAATCTG) (HYPH -) (CD 3) (SYM ′)))) (: ;) (NP (NP (JJ forward) (NN primer)) (, ,) (NP (NML (NN PGK) (HYPH /) (NN F)) (NML (CD 5) (SYM ′)) (HYPH -) (NN CTGTGGTACTGAGAGCAGCAAGA) (HYPH -) (CD 3) (SYM ′))) (: ;) (NP (NP (NN probe)) (, ,) (NP (NML (NN PGK) (HYPH /) (NN P)) (NML (CD 5) (SYM ′)) (HYPH -) (PRN (-LRB- -LRB-) (NP (CD 6) (HYPH ∼) (NN FAM)) (-RRB- -RRB-)) (NN TAGCTCGACCCA) (HYPH -) (NN CAGCCTCGGCATAT) (PRN (-LRB- -LRB-) (NP (NN TAMRA)) (-RRB- -RRB-)) (HYPH -) (PRN (-LRB- -LRB-) (NP (NN phosphate)) (-RRB- -RRB-)) (HYPH -) (CD 3) (SYM ′))) (. .)) )
( (FRAG (PP (IN For) (NP (NN VEGF) (HYPH -) (NN A))) (: :) (NP (NP (NP (JJ reverse) (NN primer)) (, ,) (NP (NML (NN VEGF) (HYPH /) (NN R)) (NML (CD 5) (SYM ′)) (HYPH -) (NN ATCCGCATGATCTGCATGG) (HYPH -) (CD 3) (SYM ′))) (: ;) (NP (NP (JJ forward) (NN primer)) (, ,) (NP (NML (NN VEGF) (HYPH /) (NN F)) (NML (CD 5) (SYM ′)) (HYPH -) (NN AGTCCCATGAAGTGATCAAGTTCA) (HYPH -) (CD 3))) (: ;) (NP (NP (NN probe)) (, ,) (NP (NML (NN VEGF) (HYPH /) (NN P)) (PRN (-LRB- -LRB-) (NP (CD 6) (HYPH ∼) (NN FAM)) (-RRB- -RRB-)) (NN TGCCCACGTCAGAGAGCAACATCAC) (PRN (-LRB- -LRB-) (NP (NN BHQ) (HYPH ∼) (CD 6) (HYPH ∼) (NN FAM)) (-RRB- -RRB-))))) (. .)) )
( (FRAG (PP (IN For) (NP (NN GLUT4))) (: :) (NP (NP (NP (JJ reverse) (NN primer)) (, ,) (NP (NML (NML (NN GLUT) (HYPH -) (CD 4)) (HYPH /) (NN R)) (NML (CD 5) (SYM ′)) (HYPH -) (NN CCCATGCCGACAATGAAGTT) (HYPH -) (CD 3) (SYM ′))) (: ;) (NP (NP (JJ forward) (NN primer)) (, ,) (NP (NML (NML (NN GLUT) (HYPH -) (CD 4)) (HYPH /) (NN F)) (NML (CD 5) (SYM ′)) (HYPH -) (NN TGTGGCCTTCTTTGAGATTGG) (HYPH -) (CD 3) (SYM ′))) (: ;) (NP (NP (NN probe)) (, ,) (NP (NML (NML (NN GLUT) (HYPH -) (CD 4)) (HYPH /) (NN P)) (NML (CD 5) (SYM ′)) (PRN (-LRB- -LRB-) (NP (CD 6) (HYPH -) (NN FAM)) (-RRB- -RRB-)) (NN TGGCCCCATTCCCTGGTTCATT) (PRN (-LRB- -LRB-) (NP (NN BHQ1) (HYPH -) (NN Q)) (-RRB- -RRB-)) (HYPH -) (CD 3) (SYM ′)))) (. .)) )
( (FRAG (PP (IN For) (NP (NN PFK) (HYPH -) (NN M))) (: :) (NP (NP (NP (JJ reverse) (NN primer)) (, ,) (NP (NML (NML (NN PFK) (HYPH -) (NN M)) (HYPH /) (NN R)) (NML (CD 5) (SYM ′)) (HYPH -) (NN AAGTCGTGCAGATGGTGTTCAG) (HYPH -) (CD 3) (SYM ′))) (: ;) (NP (NP (JJ forward) (NN primer)) (, ,) (NP (NML (NML (NN PFK) (HYPH -) (NN M)) (HYPH /) (NN F)) (NML (CD 5) (SYM ′)) (HYPH -) (NN GCCACGGTTTCCAATAACGT) (HYPH -) (CD 3) (SYM ′))) (: ;) (NP (NP (NN probe)) (, ,) (NP (NML (NML (NN PFK) (HYPH -) (NN M)) (HYPH /) (NN P)) (NML (CD 5) (SYM ′)) (HYPH -) (PRN (-LRB- -LRB-) (NP (CD 6) (HYPH -) (NN FAM)) (-RRB- -RRB-)) (NN CCTGGGTCAGACTTCAGCATCGGG) (PRN (-LRB- -LRB-) (NP (NN BHQ1) (HYPH -) (NN Q)) (-RRB- -RRB-)) (HYPH -) (CD 3) (SYM ′)))) (. .)) )
( (FRAG (PP (IN For) (NP (NN LDH) (HYPH -) (NN A))) (: :) (NP (NP (NP (JJ reverse) (NN primer)) (, ,) (NP (NML (NML (NN LDH) (HYPH -) (NN A)) (HYPH /) (NN R)) (NML (CD 5) (SYM ′)) (HYPH -) (NN ATGCACCCGCCTAAGGTTCTT) (HYPH -) (CD 3) (SYM ′))) (: ;) (NP (NP (JJ forward) (NN primer)) (, ,) (NP (NML (NML (NN LDH) (HYPH -) (NN A)) (HYPH /) (NN F)) (NML (CD 5) (SYM ′)) (HYPH -) (NN TGCCTACGAGGTGATCAAGCT) (HYPH -) (CD 3) (SYM ′))) (: ;) (NP (NP (NN probe)) (, ,) (NP (NML (NML (NN LDH) (HYPH -) (NN A)) (HYPH /) (NN P)) (NML (CD 5) (SYM ′)) (HYPH -) (PRN (-LRB- -LRB-) (NP (CD 6) (HYPH -) (NN FAM)) (-RRB- -RRB-)) (NN TGGCAGACTTGGCTGAGAGCAT) (PRN (-LRB- -LRB-) (NP (NN BHQ1) (HYPH -) (NN Q)) (-RRB- -RRB-)) (HYPH -) (CD 3) (SYM ′)))) (. .)) )
( (S (PP (IN For) (NP (NP (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression))) (PP (IN due) (IN to) (NP (NN exercise))))) (, ,) (NP-SBJ-1 (ADJP (NN age) (HYPH -) (VBN matched)) (JJ male) (NNS mice) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 6))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN run) (NP-1 (-NONE- *)) (PP (IN on) (NP (NP (DT a) (NN treadmill)) (PP (IN at) (NP (NP (CD 25) (NNS m)) (PP (SYM /) (NP (NN min))))))) (PP-TMP (IN for) (NP (CD 30) (NNS min))))) (. .)) )
( (S (PP-TMP (VBG Following) (NP (DT the) (NN run))) (, ,) (S (S (NP-SBJ-1 (NNS mice)) (VP (VBD were) (VP (VBN euthanized) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2 (NN RNA)) (VP (VBD was) (VP (VBN isolated) (CC and) (VBN analyzed) (NP-2 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN described) (NP-3 (-NONE- *)) (ADVP (RB above))))))))) (. .)) )
( (HEADING (NP (NP (NN Analysis)) (PP (IN of) (NP (NN enzyme) (NN activity) (NNS levels))))) )
( (S (PP (IN For) (NP (NP (NNS changes)) (PP (IN in) (NP (NN enzyme) (NN activity) (NNS levels))) (PP (IN with) (NP (NN exercise))))) (, ,) (NP-SBJ-1 (NNS mice) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 12))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN run) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NN treadmill))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (JJ same) (NN protocol)) (PP (IN as) (PP (IN for) (NP (DT the) (NML (NN gene) (NN expression)) (NN analysis))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NN Tissue)) (VP (VBD was) (VP (VBN harvested) (NP-1 (-NONE- *)) (PP (PP-TMP (IN after) (NP (DT the) (NN run))) (CC and) (PP (IN from) (NP (VBG resting) (NNS mice)) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 6))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 10))))) (-RRB- -RRB-))))))) (, ,) (CC and) (S (NP-SBJ-4 (NNS enzymes)) (VP (VBD were) (VP (VBN extracted) (NP-4 (-NONE- *)) (CC and) (VBN analyzed) (NP-4 (-NONE- *)) (ADVP (RB spectrophotometrically)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-2 (-NONE- *)) (CIT (-LRB- -LRB-) (NNP Reichmann) (FW et) (FW al.) (CD 1983) (-RRB- -RRB-)) (, ,) (PP (IN with) (NP (DT the) (NN exception) (SBAR (IN that) (S (NP-SBJ-3 (NP (NN fructose) (CD 1)) (, ,) (NP-ADV (CD 6) (HYPH -) (NN bisphosphate))) (VP (VBD was) (VP (VBN replaced) (NP-3 (-NONE- *)) (PP (IN with) (NP (NP (NN fructose) (CD 2)) (, ,) (NP-ADV (CD 6) (HYPH -) (NN bisphosphate)))) (PP-PRP (IN for) (NP (NP (NN stabilization)) (PP (IN of) (NP (NN PFK))))))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Units)) (PP (IN of) (NP (NN activity)))) (VP (VBD were) (VP (VBN normalized) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NNS milligrams)) (PP (IN of) (NP (JJ total) (NN protein))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (NML (NN BCA) (NN protein)) (NN quantification) (NN kit) (PRN (-LRB- -LRB-) (NP (NP (NNP Pierce) (NNP Biotechnology)) (, ,) (NP-LOC (NNP Rockford)) (, ,) (NP-LOC (NNP Illinois)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))) (. .)) )
( (HEADING (NP (NML (NML (NN Creatine) (NN kinase)) (, ,) (NML (NN serum) (NN lactate)) (, ,) (NN hematocrit) (, ,) (CC and) (NN hemoglobin)) (NNS levels) (. .))) )
( (S (NP-SBJ-1 (NN Creatine) (NN kinase) (NNS levels)) (VP (VBD were) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NN serum)) (PP (IN from) (NP (NP (NN WT) (NNS mice)) (CC and) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))))) (PP (NP-ADV (CD 24) (NNS h)) (IN after) (NP (ADJP (NN running) (HYPH -) (VBN induced)) (NN exhaustion))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT a) (NN kit)) (PP (IN from) (NP (NNP Sigma) (PRN (-LRB- -LRB-) (NP (NP (NNP St.) (NNP Louis)) (, ,) (NP-LOC (NNP Missouri)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Creatine) (NN kinase) (NNS isoforms)) (VP (VBD were) (VP (VP (VBN analyzed) (NP-1 (-NONE- *)) (ADVP (RB enzymatically))) (CC and) (VP (ADVP-TMP (RB then)) (VBN fractionated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN gel) (NN electrophoresis)))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Serum) (NN lactate)) (NNS levels)) (VP (VBD were) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (DT the) (NNP UCSD) (NNP Comparative) (NNP Neuromuscular) (NNP Laboratory))) (PP (IN from) (NP (NP (NN blood)) (VP (VBN obtained) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NP (JJ cardiac) (NN puncture)) (PP (IN from) (NP (NP (NP (CD six) (NN WT) (NNS mice)) (CC and) (NP (CD six) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (PP-TMP (VBG following) (NP (NP (NML (CD 25) (NN min)) (NN running) (NN time)) (PP (IN on) (NP (NP (DT the) (NN treadmill) (NN ramp)) (PP (IN at) (NP (NP (CD 25) (NNS m)) (PP (SYM /) (NP (NN min)))))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Hematocrit) (CC and) (NN hemoglobin)) (NNS levels)) (VP (VBD were) (VP (VBN measured) (NP-1 (-NONE- *)) (PP (IN from) (NP (VBG resting) (NNS mice) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 6))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-)))) (PP (IN by) (NP-LGS (DT the) (NNP UCSD) (NML (NML (NNP Animal) (NNP Care)) (NNP Program)) (NNP Diagnostic) (NNP Laboratory))))) (. .)) )
( (HEADING (NP (NML (NN Glucose) (NN tolerance)) (NN curve) (. .))) )
( (S (NP-SBJ-1 (NNS Animals)) (VP (VBD were) (VP (VBN assigned) (NP-1 (-NONE- *)) (PP (IN into) (NP (CC either) (NP (DT a) (NN sham) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-))) (CC or) (NP (NML (NN glucose) (NN tolerance)) (NN group) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 8))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 8))))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Experimental) (NNS animals)) (VP (VBD were) (VP (VBN injected) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NML (NP (CD 0.3) (NNS g)) (PP (SYM /) (NP (NN ml)))) (NN glucose)) (PP (IN in) (NP (NN PBS))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB achieve) (NP (NP (DT a) (NN dosage)) (PP (IN of) (NP (NP (CD 2) (NNS g)) (PP (SYM /) (NP (NN kg))))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Sham) (NNS animals)) (VP (VBD were) (VP (VBN injected) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT an) (JJ equivalent) (NN amount)) (PP (IN of) (NP (NN PBS))))))) (. .)) )
( (S (NP-SBJ-1 (NN Blood)) (VP (VBD was) (VP (VBN drawn) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NN tail))) (PP (IN at) (NP (NP (NN time) (NNS intervals)) (PP (IN of) (NP (NML (CD 0) (, ,) (CD 15) (, ,) (CD 30) (, ,) (CD 60) (, ,) (CC and) (CD 120)) (NNS min))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Samples)) (VP (VBD were) (ADVP (RB then)) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB isolate) (NP (NN plasma))))))) (. .)) )
( (S (NP-SBJ-1 (NN Plasma) (NN blood) (NN glucose)) (VP (VBD was) (VP (VBN quantified) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NNP Infinity) (NN Glucose) (NN Kit) (PRN (-LRB- -LRB-) (NP (NNP Sigma)) (-RRB- -RRB-))))))) (. .)) )
( (HEADING (NP (NML (NN Calcium) (NN uptake)) (NNS measurements) (. .))) )
( (S (NP-SBJ-1 (JJ Intact) (JJ individual) (NN muscle) (NNS fibers) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 6))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-))) (VP (VBD were) (ADVP (RB mechanically)) (VP (VP (VBN dissected) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NN flexor) (NN brevis) (NN muscle)))) (CC and) (VP (VBN loaded) (NP-1 (-NONE- *)) (PP (IN with) (NP (NN fura) (HYPH -) (CD 2)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Fibers)) (VP (VBD were) (ADVP (RB then)) (VP (VBN stimulated) (NP-1 (-NONE- *)) (SBAR-ADV (IN while) (S (NP-SBJ-2 (NP (NN force) (NN generation)) (CC and) (NP (NML (NN Ca2) (SYM +)) (NN release))) (VP (VBD were) (VP (VBN monitored) (NP-2 (-NONE- *)))))))) (. .)) )
( (HEADING (NP (NML (CD Four) (HYPH -) (NN day)) (NN endurance) (NN test))) )
( (S (NP-SBJ-1 (NN Endurance)) (VP (VBD was) (VP (VBN tested) (NP-1 (-NONE- *)) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG running) (NP (CD 24) (NNS animals) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 10))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 14))))) (-RRB- -RRB-))) (PP (IN on) (NP (NP (DT the) (NNP Omnipacer) (NN Treadmill)) (CC or) (NP (DT the) (NML (VBN enclosed) (HYPH -) (NN chamber)) (JJ modular) (NN treadmill)))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (JJ same) (NN exhaustion) (NN protocol)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB above))))))))))) (. .)) )
( (S (NP-SBJ (NNS Mice)) (VP (VBD ran) (PP (VBG according) (PP (IN to) (NP (DT this) (NN protocol)))) (NP-TMP (DT every) (NN day)) (PP-TMP (IN for) (NP (CD 4) (NNS d))) (PP (IN with) (NP (NP (DT a) (NN minimum)) (PP (IN of) (NP (NP (CD 22) (NNS h)) (PP (IN of) (NP (NN rest))))) (PP-TMP (IN between) (NP (NNS trials)))))) (. .)) )
( (S (PP (VBG Following) (NP (DT the) (JJ fourth) (NN trial))) (, ,) (NP-SBJ-1 (NNS mice)) (VP (VBD were) (VP (VP (VBN given) (NP-1 (-NONE- *)) (NP (NP (CD 24) (NNS h)) (PP (IN of) (NP (NN rest))))) (CC and) (VP (ADVP (RB then)) (VBN euthanized) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (NN Tissue)) (VP (VBD was) (VP (VBN harvested) (CC and) (VBN stained) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NN hematoxylin) (HYPH -) (NN eosin) (PRN (-LRB- -LRB-) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP (RB above))))) (-RRB- -RRB-))) (CC and) (NP (NP (NN α) (HYPH -) (NN PCNA) (PRN (-LRB- -LRB-) (NP (NP (NNP Pharmingen)) (, ,) (NP-LOC (NNP San) (NNP Diego)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (VP (VBN combined) (NP (-NONE- *)) (PP (IN with) (NP (DT a) (NN DAB) (NN Kit) (PRN (-LRB- -LRB-) (NP (NP (NNP Vector) (NNP Labs)) (, ,) (NP-LOC (NNP Burlingame)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))))))))))) (. .)) )
( (HEADING (NP (JJ Statistical) (NN analysis))) )
( (S (NP-SBJ-1 (JJ Statistical) (NNS analyses) (PRN (-LRB- -LRB-) (NP (JJ unpaired) (NP (NNP Student) (POS 's)) (NML (NN t) (HYPH -) (NN test))) (, ,) (NP (NML (NNP Mann) (HYPH -) (NNP Whitney)) (NN test)) (, ,) (NP (NNP ANOVA)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NNP StatView) (NN software) (PRN (-LRB- -LRB-) (NP (NP (NNP SAS) (NNP Institute)) (, ,) (NP-LOC (NNP Cary)) (, ,) (NP-LOC (NNP North) (NNP Carolina)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-))) (CC or) (NP (NNP Prism) (NN software) (PRN (-LRB- -LRB-) (NP (NP (NNP GraphPad) (NNP Software)) (, ,) (NP-LOC (NNP San) (NNP Diego)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))))) (. .)) )
( (HEADING (NP (NNS Abbreviations))) )
( (NP (NP (NN B) (HYPH -) (NN HAD)) (: -) (NP (NN beta) (HYPH -) (NN hydroxyacyl) (NN CoA) (NN dehydrogenase))) )
( (NP (NP (NN CS)) (: -) (NP (NN citrate) (NN synthase))) )
( (NP (NP (NN GLUT4)) (: -) (NP (NN glucose) (NN transporter) (CD 4))) )
( (NP (NP (NN HIF) (HYPH -) (NN 1α)) (: -) (NP (ADJP (NN hypoxia) (HYPH -) (JJ inducible)) (NN factor) (NN 1α))) )
( (NP (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO)) (: -) (NP (NML (JJ skeletal) (HYPH -) (NN muscle)) (NML (NN HIF) (HYPH -) (NN 1α)) (NN knockout) (NN mouse))) )
( (NP (NP (NN HMP)) (: -) (NP (NN hexose) (NN monophosphate))) )
( (NP (NP (NN LDH) (HYPH -) (NN A)) (: -) (NP (NN lactate) (NN dehydrogenase) (HYPH -) (NN A))) )
( (NP (NP (NN MCK)) (: -) (NP (NN muscle) (NN creatine) (NN kinase))) )
( (NP (NP (NN PAS)) (: -) (NP (JJ periodic) (NN acid) (HYPH –) (NN Schiff))) )
( (NP (NP (NN PCNA)) (: -) (NP (VBG proliferating) (JJ cellular) (JJ nuclear) (NN antigen))) )
( (NP (NP (NN PCr)) (: -) (NP (NN phosphocreatine))) )
( (NP (NP (NN PFKD)) (: -) (NP (NN phosphofructokinase) (NN disease))) )
( (NP (NP (NN PFK) (HYPH -) (NN M)) (: -) (NP (NP (ADJP (NN muscle) (HYPH -) (JJ specific)) (NN form)) (PP (IN of) (NP (NN phosphofructokinase))))) )
( (NP (NP (NN PGK)) (: -) (NP (NN phosphoglycerate) (NN kinase))) )
( (NP (NP (NN PK)) (: -) (NP (NN pyruvate) (NN kinase))) )
( (NP (NP (NN RER)) (: -) (NP (JJ respiratory) (NN exchange) (NN ratio))) )
( (NP (NP (NN VEGF)) (: -) (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor))) )
( (NP (NP (NN WT)) (: -) (NP (JJ wild) (HYPH -) (NN type))) )
( (HEADING (NP (NNS Figures) (CC and) (NNS Tables))) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (HEADING (NP (NP (NP (NN Exercise) (NN Capacity)) (PP (IN of) (NP (JJ Cardiac) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))) (CC and) (NP (NP (NN HIF) (HYPH -) (NN 1α)) (HYPH /) (NP (NN MCK)) (HYPH /) (NP (NN cre) (JJ Mitochondrial) (NN Density))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ (NP (NNS Mice)) (VP (VBG lacking) (NP (JJ cardiac) (NML (NN HIF) (HYPH -) (NN 1α))))) (VP (VBP perform) (ADVP (ADVP (RB no) (RB differently) (PP (IN in) (NP (NML (NN endurance) (NN running)) (NNS trials)))) (PP (IN than) (NP (NN WT) (NNS mice)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG showing) (SBAR (IN that) (S (NP-SBJ (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN exercise) (NN capacity)))) (VP (VBN seen) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN MCK) (HYPH /) (NN Cre)) (NNS mice))))) (VP (VBZ is) (PP-PRD (IN due) (IN to) (NP (NP (NN deletion)) (PP (IN of) (NP (NN HIF) (HYPH -) (NN 1α))) (PP-LOC (IN in) (NP (NP (JJ skeletal) (NN muscle)) (, ,) (CC not) (NP (JJ cardiac) (NN tissue)))))))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP-SBJ (NP (NNS Mice)) (VP (VBG lacking) (NP (JJ skeletal) (NN muscle) (NML (NN HIF) (HYPH -) (NN 1α))))) (VP (VBP have) (NP (NP (DT a) (ADJP (JJ slight) (CC but) (JJ nonsignificant)) (NN increase)) (PP (IN in) (NP (JJ mitochondrial) (NN density)))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS mitochondria))) (PP (IN per) (NP (NP (NML (NN electron) (NN microscope)) (NN field)) (PP (IN of) (NP (NN view))))))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (HEADING (NP (NP (NML (NN Hematocrit) (CC and) (NN Hemoglobin)) (NNS Levels)) (PP-LOC (IN in) (NP (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (CC and) (NP (NN WT) (NNS Mice)))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ (NN Hematocrit) (NNS levels)) (VP (VBP are) (ADJP-PRD (RB virtually) (JJ identical)) (PP-LOC (IN in) (NP (NML (CC both) (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 3)))) (-RRB- -RRB-))) (CC and) (NML (NN WT) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 4)))) (-RRB- -RRB-)))) (NNS mice))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (NN HIF) (HYPH -) (NN 1α))) (PP-LOC (IN in) (NP (JJ skeletal) (NN muscle)))) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (NML (NN oxygen) (VBG carrying)) (NN capacity)) (PP (IN of) (NP (DT the) (NN blood))))))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (NP (JJ similar) (NN hematocrit) (NNS levels))))) (, ,) (NP-SBJ (NP (NN WT) (NNS mice)) (CC and) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (VP (VBP have) (NP (ADJP (RB very) (JJ close)) (NML (NN blood) (NN hemoglobin)) (NNS levels))) (. .))) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (HEADING (NP (NP (JJ Intramuscular) (NN Metabolite) (NNS Levels)) (PP (PP (IN at) (NP (NN Rest))) (CC and) (PP-TMP (IN Following) (NP (NN Stimulation)))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ-1 (JJ Glycolytic) (NNS intermediates)) (VP (VBD were) (VP (VBN measured) (NP-1 (-NONE- *)) (PP (IN from) (NP (NN gastrocnemius) (NNS muscles))) (PP-TMP (IN following) (NP (DT the) (VBN isolated) (NN stimulation) (NN protocol))))) (. .))) )
( (CAPTION (S (NP-SBJ (VBG Resting) (NNS values)) (VP (VBP represent) (NP (NP (NNS levels)) (PP-LOC (IN in) (NP (NP (DT the) (JJ unstimulated) (NN gastrocnemius)) (PP (IN from) (NP (DT the) (JJ same) (NNS animals))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBD had) (NP (NP (DT a) (NN trend)) (PP (IN toward) (NP (NP (JJR greater) (VBN accumulated) (NNS levels)) (PP (IN of) (NP (NNS HMPs))))) (PP-TMP (IN during) (NP (DT the) (NN stimulation) (NN protocol)))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (DT the) (NN difference)) (VP (VBD did) (RB not) (VP (VB reach) (NP (JJ statistical) (NN significance) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.10)))) (-RRB- -RRB-)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT This) (NN difference)) (VP (MD could) (VP (VB be) (ADJP-PRD (JJ indicative) (PP (IN of) (NP (NP (DT a) (NN blockage)) (PP-LOC (IN in) (NP (DT the) (JJ glycolytic) (NN pathway))) (PP (IN at) (NP (NN PFK)))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP-SBJ-1 (DT No) (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN between) (NP (NP (NML (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (CC and) (NN WT)) (JJ intramuscular) (NN glucose) (NNS levels)) (PP (PP (IN at) (NP (NN rest))) (CC or) (PP-TMP (IN following) (NP (NN stimulation)))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NML (CC Both) (NML (NN HIF) (HYPH -) (NN 1α)) (NML (NN KO) (CC and) (NN WT))) (NNS muscles)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (ADVP (RB significantly)) (VP (VB increase) (NP (NN glucose) (NN uptake)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG leading) (PP (IN to) (NP (NP (JJR greater) (NNS levels)) (PP (IN of) (NP (JJ intramuscular) (NN glucose))) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (NN stimulation) (PRN (-LRB- -LRB-) (FRAG (NP (NN WT)) (, ,) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.001))))) (: ;) (FRAG (NP (NN KO)) (, ,) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.05))))) (-RRB- -RRB-))))))))))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBP have) (NP (NP (JJR more) (VBN stored) (NN glycogen)) (SBAR (IN than) (SINV (VP (VBP do) (VP (-NONE- *?*))) (NP-SBJ (NN WT) (NNS mice)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Glycogen) (NNS levels)) (VP (VBD were) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-TMP (VBG following) (NP (NP (DT the) (JJ same) (NN stimulation) (NN protocol)) (PP (IN as) (PP (IN in) (-LRB- -LRB-) (NP (NN B)))))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NN change)) (PP (IN in) (NP (NN glycogen))) (PP (PP (IN from) (NP (NN rest))) (PP (IN to) (NP (NN poststimulation))))) (VP (VBD was) (ADVP (RB also)) (ADJP-PRD (JJR greater)) (PP-LOC (IN in) (NP (DT the) (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (PRP they)) (VP (VBD metabolized) (NP (JJR more) (NN glycogen)) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (NN stimulation) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.01)))) (: ;) (S-FRM (NP-SBJ (SYM *) (NN p)) (VP (SYM <) (NP (CD 0.05)))) (, ,) (NP (NP (NP (NN WT)) (PP (IN at) (NP (NN rest)))) (CC vs.) (NP (NP (NN KO)) (PP (IN at) (NP (NN rest))))) (-RRB- -RRB-)))))))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBP utilize) (NP (NP (JJR more) (NN PCr)) (SBAR-1 (-NONE- *ICH*))) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (NN stimulation))))) (SBAR-1 (IN than) (SINV (VP (VBP do) (VP (-NONE- *?*))) (NP-SBJ (NN WT) (NNS mice))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (NP (JJ Similar) (NNS levels)) (PP (IN of) (NP (NN PCr)))) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN at) (NP (NN rest)))))) (, ,) (CC but) (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VP (VBD metabolized) (ADVP (RB significantly) (RBR more)) (PP-TMP (IN during) (NP (NN stimulation))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (CC and) (VP (VBD had) (NP (NP (ADJP (RB much) (JJR lower)) (NNS levels)) (PP (VBG following) (NP (DT the) (NN protocol) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM **) (NN p)) (VP (SYM <) (NP (CD 0.01)))) (, ,) (NP (NP (NN WT) (RB poststimulation)) (CC vs.) (NP (NN KO) (RB poststimulation))) (-RRB- -RRB-)))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP-SBJ-1 (NP (DT A) (NN trend)) (PP (IN toward) (NP (JJR lower) (NML (NN PCr) (HYPH /) (NN ATP)) (NN concentration) (NNS ratios)))) (VP (VBD was) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ relative) (PP (IN to) (NP (NN WT) (NNS mice))))) (PP-TMP (IN following) (NP (NN stimulation))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (DT the) (NN difference)) (VP (VBD did) (RB not) (ADVP (RB quite)) (VP (VB reach) (NP (JJ statistical) (NN significance)) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.10)))) (-RRB- -RRB-)))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT A) (NN trend)) (PP (IN toward) (NP (NP (DT a) (JJR greater) (NN drop)) (PP (PP (IN from) (NP (NN rest))) (PP (IN to) (NP (NN poststimulation)))) (PP (IN in) (NP (DT the) (NML (NN PCr) (HYPH /) (NN ATP)) (NN ratio)))))) (VP (VBD was) (ADVP (RB also)) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (PP-TMP (IN following) (NP (NN stimulation))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.10)))) (-RRB- -RRB-)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ-2 (PRP they)) (VP (VBD had) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB rely) (ADVP (RBR more) (RB heavily)) (PP (IN on) (NP (NN PCr))) (PP (IN for) (NP (NN ATP) (NN generation))))))))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS F) (-RRB- -RRB-)) (NP-SBJ-1 (ADJP (JJ Slight) (CC but) (JJ nonsignificant)) (NNS differences)) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (JJ whole) (HYPH -) (NN muscle)) (NN ATP) (NNS levels))) (PP (PP (IN at) (NP (NN rest))) (CC or) (PP-TMP (IN following) (NP (NN stimulation)))))) (. .))) )
( (CAPTION (S (SBAR-ADV (IN Although) (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBD exhibited) (NP (VBN altered) (NN substrate) (NN utilization))))) (, ,) (NP-SBJ-1 (PRP they)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB meet) (NP (PRP$ their) (NN ATP) (NNS demands)) (PP-TMP (IN during) (NP (DT the) (NN protocol)))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS G) (-RRB- -RRB-)) (S (NP-SBJ (NML (CC Both) (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (CC and) (NN WT)) (NNS animals)) (VP (VBD produced) (NP (JJ significant) (JJ intramuscular) (NN lactate)) (PP-TMP (IN during) (NP (DT the) (NN stimulation) (NN protocol))))) (: ;) (S (ADVP (RB however)) (, ,) (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (DT no) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN amount)) (VP (VBN produced) (NP (-NONE- *)) (PP-MNR (IN by) (NP (DT either) (NN genotype))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (VBG Resting) (JJ intramuscular) (NN lactate) (NNS levels)) (VP (VBD were) (ADVP (RB also)) (ADJP-PRD (JJ similar) (PP (IN for) (NP (NP (NNS WTs)) (CC and) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (HEADING (NP (NP (NP (NN Force) (NN Generation)) (CC and) (NP (NML (NN Ca2) (SYM +)) (NN Release))) (PP-LOC (IN in) (NP (VBN Isolated) (NN Muscle) (NNS Fibers))) (PP-TMP (IN during) (NP (NN Stimulation))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ-1 (DT No) (NNS differences)) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN in) (NP (JJ total) (NN force) (NN generation))) (PP-LOC (IN in) (NP (VBN isolated) (NN muscle) (NNS fibers))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (ADJP (RB Mechanically) (VBN dissected)) (NNS fibers)) (PP (IN from) (NP (DT the) (NN flexor) (NN brevis) (NN muscle)))) (VP (VBD were) (VP (VBN subjected) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT a) (NN fatiguing) (NN protocol))))) (. .))) )
( (CAPTION (S (NP-SBJ (ADJP (CC Neither) (JJ initial) (CC nor) (JJ final)) (NNS forces)) (VP (VBD differed) (PP (IN between) (NP (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO) (CC and) (NN WT)) (NNS fibers)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP-SBJ (NP (NP (NML (NN Ca2) (SYM +)) (NN release)) (CC and) (NP (NN reuptake))) (PP-LOC (IN in) (NP (NML (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO)) (CC and) (NN WT)) (NNS fibers)))) (VP (VBD was) (RB not) (ADJP-PRD (JJ different)) (PP-TMP (IN during) (NP (DT the) (NN stimulation) (NN protocol)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NML (NN Ca2) (SYM +)) (NNS levels)) (VP (VBD were) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (JJ individual) (NNS fibers))) (PP-MNR (IN through) (NP (NP (NN use)) (PP (IN of) (NP (NML (NN fura) (HYPH -) (CD 2)) (NML (NN Ca2) (SYM +)) (NN indicator))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (VBN altered) (NN substrate) (NN utilization)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN ability) (S-1 (-NONE- *ICH*))) (PP (IN of) (NP (DT the) (NNS fibers))) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB maintain) (NP (JJ proper) (NML (NN Ca2) (SYM +)) (NN flux)))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (HEADING (NP (NP (NP (JJ Oxidative) (NN Metabolism)) (CC and) (NP (NN Serum) (NN Lactate) (NN Production))) (PP-LOC (IN in) (NP (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (CC and) (NP (NN WT) (NNS Mice)))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBP have) (NP (NP (JJR higher) (NN resting) (NNS levels)) (PP (IN of) (NP (NN CS) (NN activity))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN CS)) (VP (VBZ is) (NP-PRD (NP (NP (DT an) (NN enzyme)) (PP (IN in) (NP (DT the) (NNP Krebs) (NN cycle)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD can) (VP (VB be) (VP (VBN regulated) (NP-1 (-NONE- *)) (ADVP (RB allosterically)) (PP-MNR (IN by) (NP (NN ATP) (NNS levels)))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (VBN Increased) (NN CS) (NN activity)) (VP (VBZ is) (ADJP-PRD (JJ indicative) (PP (IN of) (NP (NP (VBN increased) (NN muscle) (JJ oxidative) (NN capacity)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (ADJP-PRD (JJ common)) (PP-LOC (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (JJ glycogenolytic) (CC or) (JJ glycolytic)) (NNS myopathies)))))))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM #) (NN p)) (VP (SYM <) (NP (CD 0.10)))) (, ,) (NP (NP (NN KO)) (CC vs.) (NP (NN WT))) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBP have) (NP (NP (JJR higher) (VBG resting) (NNS levels)) (PP (IN of) (NP (NP (NML (NN B) (HYPH -) (NN HAD)) (NN activity)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (ADJP-PRD (JJ indicative) (PP (IN of) (NP (DT a) (JJR greater) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB oxidize) (NP (JJ fatty) (NNS acids))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM **) (NN p)) (VP (SYM <) (NP (CD 0.01)))) (, ,) (NP (NN WT) (CC vs.) (NN KO)) (-RRB- -RRB-)))))))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP-SBJ-1 (JJ Lower) (NML (NN serum) (NN lactate)) (NNS levels)) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (PP-TMP (IN following) (NP (DT a) (VBN timed) (NML (CD 25) (HYPH -) (NN minute)) (NN run))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM *) (NN p)) (VP (SYM <) (NP (CD 0.05)))) (, ,) (NP (NN WT) (CC vs.) (NN KO)) (-RRB- -RRB-)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 6))) )
( (HEADING (NP (NP (NN Endurance) (NNS Capabilities)) (PP (IN of) (NP (JJ Untrained) (NNS Mice))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBP have) (NP (NP (JJR greater) (NN endurance)) (PP (IN in) (NP (NN swimming) (NNS tests)))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (PRP$ their) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB swim) (PP (IN on) (ADJP (JJ average))) (ADVP (ADVP (NP (QP (JJR more) (IN than) (CD 45)) (NNS min)) (RBR longer)) (PP (IN than) (NP (NN WT))))))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM *) (NN p)) (VP (SYM <) (NP (CD 0.05)))) (, ,) (NP (NN WT) (CC vs.) (NN KO)) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBP have) (NP (NP (JJR greater) (NN endurance)) (PP (IN than) (NP (NN WT) (NNS mice)))) (PP (IN in) (NP (JJ uphill) (NN running) (NNS tests)))) (. .))) )
( (CAPTION (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (RB only) (DT a) (NML (CD 10) (HYPH -) (NN min)) (NN difference)) (VP (VBZ is) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-TMP (IN between) (NP (NN run) (NNS times))))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ is) (S-PRD (NP-SBJ-3 (-NONE- *PRO*)) (VP (TO to) (VP (VB be) (VP (VBN noted) (NP-3 (-NONE- *)))))) (SBAR-2 (IN that) (S (PP (IN because) (IN of) (NP (DT the) (NN protocol))) (, ,) (NP-SBJ (DT this) (CD 10) (NNS min)) (VP (VBD included) (NP (CD two) (NN velocity) (NNS increases))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM **) (NN p)) (VP (SYM <) (NP (CD 0.01)))) (, ,) (NP (NN WT) (CC vs.) (NN KO)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBP have) (NP (NP (JJR less) (NN endurance)) (PP (IN than) (NP (NN WT) (NNS mice)))) (PP (IN in) (NP (JJ downhill) (NN running) (NNS tests)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (JJ same) (NN protocol)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN as) (PP (IN in) (NP (NN Figure) (NN 4A)))) (, ,) (PP (IN except) (SBAR (-NONE- *0*) (S (NP-SBJ-2 (DT the) (NNS mice)) (VP (VBD were) (VP (VBN run) (NP-2 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (CD 10) (SYM °)) (NN decline)))))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM *) (NN p)) (VP (SYM <) (NP (CD 0.05)))) (, ,) (NP (NN WT) (CC vs.) (NN KO)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NN RER)) (ADVP (RB uphill) (CC vs.) (RB downhill)) (PP-LOC (IN in) (NP (NN WT) (NNS mice))) (. .))) )
( (CAPTION (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (MD would) (VP (VB be) (VP (VBN expected) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (JJ eccentric) (NNS exercises)) (VP (VBG relying) (ADVP (RBR more) (RB heavily)) (PP (IN on) (NP (JJ glycolytic) (NNS fibers))))))))))) (, ,) (NP-SBJ (DT the) (NN RER) (NNS values)) (VP (VBP are) (ADJP-PRD (ADJP (JJR higher)) (PP-2 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (NP (NNS mice)) (VP (VBG running) (ADVP (RB downhill))))) (PP-2 (IN than) (PP-LOC (IN in) (NP (NP (DT those)) (VP (VBG running) (ADVP (RB uphill))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP (NN RER)) (ADVP (RB uphill) (CC vs.) (RB downhill)) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (. .))) )
( (CAPTION (S (ADVP (RB Once) (RB again)) (, ,) (NP-SBJ-1 (NP (JJR higher) (NN RER) (NNS values)) (PP-2 (-NONE- *ICH*)) (PP-3 (-NONE- *ICH*))) (VP (VBP are) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-2 (IN for) (NP (NP (NNS mice)) (VP (VBG running) (ADVP (RB downhill))))) (PP-3 (IN than) (NP (NP (DT those)) (VP (VBG running) (ADVP (RB uphill))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 7))) )
( (HEADING (NP (NP (VBN Increased) (NN Muscle) (NN Damage)) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (PP-TMP (IN Following) (NP (VBN Repeated) (NN Exercise))))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ (NP (NN WT) (NNS mice)) (CC and) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))) (VP (VBD underwent) (NP (NP (DT a) (NML (CD 4) (HYPH -) (NN d)) (NN endurance) (NN test)) (, ,) (SBAR (WHPP-2 (IN in) (WHNP (WDT which))) (S (NP-SBJ-1 (NNS animals)) (VP (VBD were) (VP (VBN run) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN exhaustion))) (PP-TMP (IN on) (NP (NP (DT each)) (PP (IN of) (NP (CD four) (JJ successive) (NNS days))))) (PP (IN with) (NP (NP (DT a) (NN minimum)) (PP (IN of) (NP (NML (CD 22) (NN h)) (NN rest))) (PP-TMP (IN between) (NP (NNS trials))))) (PP-2 (-NONE- *T*)))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBD demonstrated) (ADVP (RB initially)) (NP (JJR greater) (NN endurance)) (PP (IN under) (NP (DT the) (NN protocol))))) (: ;) (S (ADVP (RB however)) (, ,) (S (S (PP-TMP (IN by) (NP (DT the) (JJ second) (NN day))) (, ,) (NP-SBJ-1 (PRP$ their) (NN endurance) (NN advantage)) (VP (VBD was) (VP (VBN eliminated) (NP-1 (-NONE- *))))) (, ,) (CC and) (S (PP-TMP (IN by) (NP (DT the) (JJ fourth) (NN day))) (, ,) (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBD were) (VP (VBG running) (PP (IN for) (NP (NP (DT a) (ADJP (RB significantly) (JJR shorter)) (NN time)) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (SYM **) (NN p)) (VP (SYM <) (NP (CD 0.01)))) (-RRB- -RRB-)) (PP (IN than) (PP (IN on) (NP (DT the) (JJ first) (NN day)))))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NN WT) (NNS animals)) (VP (VBD were) (VP (VBG running) (PP (IN for) (NP (NP (ADJP (RB approximately) (JJ similar)) (NNS times)) (PP (IN as) (PP (IN on) (NP (DT the) (JJ first) (NN day))))))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (VBN Repeated) (NNS measures) (NN ANOVA)) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN decrease)) (PP (IN in) (NP (NN performance))) (PP-TMP (IN on) (NP (DT each) (JJ successive) (NN day)))) (VP (VBD was) (ADJP-PRD (JJ unique) (PP (IN to) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN Example)) (PP (IN of) (NP (NP (NML (NN hematoxylin) (CC and) (NN eosin)) (NN staining)) (PP (IN of) (NP (NN gastrocnemius) (NNS muscles))))) (PP-TMP (IN after) (NP (NP (CD 1) (NN d)) (PP (IN of) (NP (NN recovery))))) (PP (IN by) (NP (NP (NNS mice)) (PP-TMP (IN after) (NP (DT the) (NML (CD 4) (HYPH -) (NN d)) (NN endurance) (NN test))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NN Evidence)) (PP (IN of) (NP (JJR greater) (NN damage)))) (VP (MD can) (VP (VB be) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO)) (NNS muscles))) (PP (VBN compared) (PP (IN to) (NP (NN WT) (NNS muscles))))))) (. .))) )
( (CAPTION (NP (-LRB- -LRB-) (LST (LS C)) (-RRB- -RRB-) (NP (NP (NN Example)) (PP (IN of) (NP (NP (NN PCNA) (NN staining)) (PP (IN of) (NP (NP (NN gastrocnemius) (NNS muscles)) (PP (IN from) (NP (VBN exercised) (NNS mice)))))))) (, ,) (VP (VBG demonstrating) (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NN muscle) (NN regeneration))) (PP-LOC (IN in) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NN Number)) (PP (IN of) (NP (ADJP (NN PCNA) (HYPH -) (JJ positive)) (NNS nuclei))) (PP (IN per) (NP (JJ square) (NN millimeter))) (PP-LOC (IN in) (NP (NP (NN gastrocnemius) (NNS muscles)) (PP (IN of) (NP (NP (NP (NN WT) (NNS mice) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 5)))) (-RRB- -RRB-))) (CC and) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 7)))) (-RRB- -RRB-)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD ran) (ADVP (RB repeatedly)) (PP-TMP (IN for) (NP (CD 4) (NNS d)))))))))) (. .))) )
( (CAPTION (S (SBAR-ADV (IN Although) (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBP have) (NP (NP (QP (RB almost) (RB twice)) (RB as) (JJ many) (ADJP (NN PCNA) (HYPH -) (JJ positive)) (NNS nuclei)) (PP (IN per) (NP (JJ square) (NN millimeter))))))) (, ,) (NP-SBJ (DT the) (NN difference)) (VP (VBZ is) (RB not) (ADJP-PRD (JJ significant)) (, ,) (PP-PRP (IN because) (IN of) (NP (NP (JJ wild) (NNS variations)) (PP-LOC (IN in) (NP (DT that) (NN population)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NML (NN F) (HYPH -) (NN test)) (NN analysis)) (PP (IN of) (NP (DT the) (NNS data)))) (VP (VBZ reveals) (SBAR (IN that) (S (NP-SBJ (DT the) (NN variance)) (VP (VBZ is) (ADJP-PRD (ADJP (RB much) (JJR greater)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO)) (NN population))) (PP-1 (IN than) (NP (DT the) (NN WT) (NN population))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-)))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 8))) )
( (HEADING (NP (NP (NN Glucose) (NN Tolerance)) (CC and) (NP (NN Glycogen) (NN Storage)))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ-1 (DT No) (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN in) (NP (VBG resting) (NML (NN blood) (NN glucose)) (NNS levels))) (PP-LOC (IN in) (NP (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (CC or) (NP (NN WT) (NNS mice)))))) (. .))) )
( (CAPTION (S (PP-TMP (IN Following) (NP (NP (NN injection)) (PP (IN of) (NP (NN glucose))) (PP (IN at) (NP (NP (DT a) (NN dosage)) (PP (IN of) (NP (NP (CD 2) (NNS g)) (PP (SYM /) (NP (NN kg))))))))) (, ,) (NP-SBJ-1 (DT no) (NNS differences)) (VP (VBD were) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (NP (DT the) (JJ maximum) (NNS levels)) (PP (IN of) (NP (NN blood) (NN glucose)))) (CC or) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN glucose) (NN disappearance)))))) (PP-LOC (IN in) (NP (DT either) (NN genotype))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (JJ Representative) (NN PAS) (NN staining)) (PP (IN of) (NP (NP (NN gastrocnemius) (NN muscle)) (PP (IN from) (NP (NP (NN WT) (NNS mice)) (CC and) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NML (NN HIF) (HYPH -) (NN 1α)) (NNS KOs)) (VP (VBP demonstrate) (NP (JJR darker) (NN staining)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (NP (JJR more) (VBN stored) (NN glycogen))))) (. .))) )
( (HEADING (NP (NN Table) (CD 1))) )
( (HEADING (NP (NP (NN Excision)) (PP (IN of) (NP (NN HIF) (HYPH -) (NN 1α))) (PP-LOC (IN in) (NP (JJ Various) (NNS Tissues))))) )
( (CAPTION (S (NP-SBJ (NN Deletion) (NNS levels)) (VP (VBP are) (NP-PRD (NP (DT the) (JJ average) (NN percent)) (PP (IN of) (NP (NP (NP (NN HIF) (HYPH -) (NN 1α)) (VP (VBN deleted) (NP (-NONE- *)))) (SYM ±) (NP (NN SE)))))))) )
( (HEADING (NP (NN Table) (CD 2))) )
( (HEADING (NP (NP (NN Fiber) (NN Typing)) (PP (IN of) (NP (NN Gastrocnemius) (NN Muscle))))) )
( (CAPTION (S (NP-SBJ (NNS Values)) (VP (VBP are) (NP-PRD (NN percent) (SYM ±) (NN SE))))) )
( (HEADING (NP (NN Table) (CD 3))) )
( (HEADING (NP (NP (NN Fiber) (NN Typing)) (PP (IN of) (NP (NN Soleus) (NN Muscle))))) )
( (CAPTION (S (NP-SBJ (NNS Values)) (VP (VBP are) (NP-PRD (NN percent) (SYM ±) (NN SE))))) )
( (CAPTION (FRAG (S-FRM (NP-SBJ (SYM *) (NN p)) (VP (SYM <) (NP (CD 0.05)))) (, ,) (NP (NP (NN WT)) (PP (IN vs.) (NP (NN KO)))))) )
( (HEADING (NP (NN Table) (CD 4))) )
( (HEADING (NP (JJ Relative) (NML (NN Gene) (NN Expression)) (NNS Levels))) )
( (CAPTION (S (NP-SBJ (NN Expression) (NNS levels)) (VP (VBP are) (NP-PRD (NP (NP (NNS means)) (ADJP (JJ relative) (PP (IN to) (NP (VBG resting) (NN WT))))) (PP (IN for) (NP (NP (DT each) (NN gene)) (SYM ±) (NP (NN SE)))))))) )
( (CAPTION (S (NP-SBJ (NN Percent) (NN increase)) (VP (VBZ indicates) (NP (NP (NN percent) (NN increase)) (PP (IN of) (NP (JJ postexercise) (JJ average) (NML (NN gene) (NN expression)))) (PP (IN over) (NP (VBG resting) (NN average))))))) )
( (S (S-FRM (NP-SBJ (SYM *) (NN p)) (VP (SYM <) (NP (CD 0.05)) (, ,) (NP-ADV (NN rest) (CC vs.) (NN postexercise)))) (: ;) (S-FRM (NP-SBJ (SYM **) (NN p)) (VP (SYM <) (NP (CD 0.01)) (, ,) (NP-ADV (NN rest) (CC vs.) (RB postexercise))))) )
( (HEADING (NP (NN Table) (CD 5))) )
( (HEADING (NP (NP (JJ Glycolytic) (NN Enzyme) (NN Activity) (NNS Levels)) (PP (IN from) (NP (NN Gastrocnemius) (NN Muscles))))) )
( (CAPTION (S (NP-SBJ (NNS Activities)) (VP (VBP are) (PP-PRD (IN in) (NP (NP (NN U)) (PP (SYM /) (NP (NP (NNS mg) (NN protein)) (SYM ±) (NP (NN SE))))))))) )
( (CAPTION (NP (NP (NP (NN GAPDH)) (, ,) (NP (NN glyceraldehyde) (NML (CD 3) (HYPH -) (NN phosphate)) (NN dehydrogenase))) (: ;) (NP (NP (NN PGI)) (, ,) (NP (NN phosphoglucose) (NN isomerase))))) )
( (S (S-FRM (NP-SBJ (SYM *) (NN p)) (VP (SYM <) (NP (CD 0.05)) (, ,) (NP (NP (NP (NN WT)) (CC vs.) (NP (NML (NN HIF) (HYPH -) (NN 1α)) (NN KO))) (PP (IN for) (NP (NP (VBN given) (VBN exercised)) (CC or) (NP (VBG resting) (NN state))))))) (: ;) (S-FRM (NP-SBJ (SYM **) (NN p)) (VP (SYM <) (NP (CD 0.05)) (, ,) (NP-ADV (NP (NN rest) (CC vs.) (NN postexercise)) (PP-LOC (IN within) (NP (VBN given) (NN genotype))))))) )
( (HEADING (NP (NNS Footnotes))) )
( (HEADING (NP (NP (NNS Conflicts)) (PP (IN of) (NP (NN interest))) (. .))) )
( (S (NP-SBJ (DT The) (NNS authors)) (VP (VBP have) (VP (VBN declared) (SBAR (IN that) (S (NP-SBJ (NP (DT no) (NNS conflicts)) (PP (IN of) (NP (NN interest)))) (VP (VBP exist)))))) (. .)) )
( (HEADING (NP (NN Author) (NNS contributions) (. .))) )
( (S (NP-SBJ (NNP RSJ)) (VP (VP (VBD conceived) (CC and) (VBD designed)) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP SDM) (, ,) (NNP RAH) (, ,) (NNP MJK) (, ,) (NNP IMO) (, ,) (NNP WM) (, ,) (NNP RPH) (, ,) (CC and) (NNP FJG)) (VP (VBD performed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP SDM) (, ,) (NNP RAH) (, ,) (NNP MJK) (, ,) (NNP IMO) (, ,) (NNP MCH) (, ,) (NNP PDW) (, ,) (NNP FJG) (, ,) (CC and) (NNP RSJ)) (VP (VBD analyzed) (NP (DT the) (NNS data))) (. .)) )
( (S (NP-SBJ (NNP CRK) (CC and) (NNP RSJ)) (VP (VBD contributed) (NP (NNS reagents) (HYPH /) (NNS materials) (HYPH /) (NN analysis) (NNS tools))) (. .)) )
( (S (NP-SBJ (NNP SDM) (CC and) (NNP RSJ)) (VP (VBD wrote) (NP (DT the) (NN paper))) (. .)) )
( (NP (NP (JJ Academic) (NN Editor)) (: :) (NP (NP (NNP Michael) (NNP Bate)) (, ,) (NP-LOC (NP (NNP University)) (PP (IN of) (NP (NNP Cambridge)))))) )
( (FRAG (NP (NN Citation)) (: :) (CIT (NNP Mason) (NNP SD) (, ,) (NNP Howlett) (NNP RA) (, ,) (NNP Kim) (NNP MJ) (, ,) (NNP Olfert) (NNP IM) (, ,) (NNP Hogan) (NNP MC) (, ,) (FW et) (FW al.) (-LRB- -LRB-) (CD 2004) (-RRB- -RRB-)) (S (NP-SBJ (NP (NN Loss)) (PP (IN of) (NP (NML (JJ skeletal) (NN muscle)) (NN HIF) (HYPH -) (CD 1α)))) (VP (VBZ results) (PP (IN in) (NP (VBN altered) (NN exercise) (NN endurance))))) (. .)) )
( (CIT (NN PLoS) (NN Biol) (CD 2) (-LRB- -LRB-) (CD 10) (-RRB- -RRB-) (: :) (NN e288) (. .)) )
